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Abstract

The purpose of the present study was to identify the relations between nine dimensions of
parents’ cognitive representations of ASD, their acceptance of their children’s ASD, and their
treatment selection for their children with ASD. Parents of children with ASD aged 21 years and
younger (N = 124) completed an online survey, with 10 of those parents completing telephone
follow-up interviews. Logistic regression analyses revealed that stronger beliefs in personal
control over one’s child’s ASD were associated with selection of medication-based treatments,
while stronger beliefs in external causes of ASD were associated with selection of metabolic
treatments. Correlation analyses also revealed that lower levels of acceptance were associated
with selecting greater numbers of treatments, regardless of empirical support. Results suggest
that programs aiming to increase parents’ acceptance and teach parents to be more “research
savvy” may help promote selection of evidence-based treatments for children with ASD.
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Introduction

What is ASD?
Autism Spectrum Disorders (ASD) are a group of neurodevelopmental disorders
associated with impairments in communication and social interest, and the presence of
stereotyped or repetitive behaviours (American Psychiatric Association [APA], 2000).
Although Leo Kanner first identified what he called “autistic disturbances of affective contact”
in 1943, it is only in recent decades that the general public has learned of ASD, primarily
through films such as Rainman and Mercury Rising, and recent media coverage highlighting
parents of children with ASD, such as celebrity mother Jenny McCarthy (Jones & Harwood,
2009). This dramatic increase in public knowledge of ASD has been accompanied by a dramatic
increase in the number of children diagnosed with ASD each year (Chakrabarti & Fombonne,
2005; Prior, 2003). Presently, it is estimated that approximately 1 in 88 children have ASD
(Centers for Disease Control and Prevention [CDC], 2012).
With ASD increasingly becoming a topic of public interest, the number of proposed
treatments for ASD has also increased (National Autism Center [NAC], 2009), with some even
claiming to offer a “cure” for children’s ASD without providing empirical support for this claim
(e.g., McCarthy, 2007). Unfortunately, upon learning that their children have ASD, parents are
often emotionally overwhelmed and vulnerable to believing these unsupported claims (Seigel,
1997). For this reason, parents’ treatment selection for their children with ASD is of particular
interest to researchers studying methods of improving access to evidence-based services among
children with ASD.
Receiving a Diagnosis of ASD
For most parents of children with ASD, receiving the diagnosis of ASD leads them to
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experience mixed emotions (Gray, 1993; Mansell & Morris, 2004; O’Brien & Daggett, 2006;
Siegel, 1997). Many parents have had to wait several months for diagnosis and experience a
sense of relief and validation that their suspicions have finally been verified (Mansell & Morris,
2004; Midence & O’Neil, 1999; Sullivan, 1997; Wachtell & Cater, 2008). Often simultaneously,
however, many parents experience shock, disbelief, and a deep sense of loss upon receiving the
diagnosis (Avdi, Griffin, & Brough, 2000; Midence and O’Neill, 1999; O’Brien & Daggett,
2006; Piper & Howlin, 1992; Wachtell & Carter, 2008). It appears that, although parents have
likely been concerned about their children’s development for several months and may have even
suspected that their children would be diagnosed with ASD, they commonly come to the
assessment appointment hoping that their suspicions will not be confirmed (Gray, 1993).
In addition to the initial shock, parents often experience emotional strain because they
feel they have not properly protected their children, or that they may have somehow inflicted
ASD on their children; they worry about their children’s future independence and realize that
they must redefine their relationship with their children to accommodate this new information
(O’Brien & Daggett, 2006). Particularly because their children do not differ in physical
appearance from children with typical development, parents often struggle with reconciling their
“post-diagnosis” child and their “pre-diagnosis” child (Mansell & Morris, 2004; O’Brien &
Daggett, 2006). As such, many parents go through a phase of grieving for “the children that
could have been”, similar to the grieving process of parents who have experienced the deaths of
their children (Mansell & Morris, 2004; Wachtell & Carter, 2008).
This process of grieving has been described as a complex experience involving shock,
denial, guilt, isolation, panic, anger, bargaining, acceptance, and hope (Valman, 1981, as cited in
Shapiro, 1983), with parents continuously cycling between periods of sadness, acceptance, and
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stress at various points in their children’s development (Tunali & Power, 1993). One parent of a
child with ASD aptly described her experience within this cycle as the following: “Initial Shock
– Denial, Anger, Disbelief, Why us? Why him? Why? – Acceptance – Anger to do something to
help him/us. Tired, frustrated, sometimes calm-ish! Always on the go, worry. A yo-yo!”
(Mansell & Morris, 2004, p. 404).
Although the stages of grieving experienced by parents after learning that their children
have ASD share many similarities with the stages of grieving experienced by parents after the
deaths of children, there are several important distinctions. First, when parents experience the
deaths of children, members of their primary support system often share their grief and act as
significant sources of comfort. When children are diagnosed with ASD, however, many parents
experience feelings of isolation from members of their primary support system, who are often
unaware of the child’s diagnosis or avoid the parents because they may be unsure about how to
behave around them. As Sullivan (1997) described:
The news of your child’s autism does not get announced in the local paper. There is no
gathering of family and friends at which your pastor solemnly announces the diagnosis.
The news sits heavily on your shoulders, and it’s up to you to decide how and when, or
even if, you announce it. (p. 1010).
Additionally, the grieving process for parents of children with ASD occurs at the same
time as they are being asked to make important decisions regarding their child’s treatment and to
plan for their child’s future (O’Brien & Daggett, 2006). These almost contradictory demands
placed on parents may serve to complicate their emotions, leading them to feel grief and hope
simultaneously. Boss (1999) termed this experience “ambiguous loss” and asserted that it often
leads parents to fail to adapt their family roles and routines to accommodate their child with
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ASD, repress their feelings of grief and mourning, question their beliefs and value systems,
experience exhaustion, and have difficulty making thoughtful decisions on behalf of their
children.
Accepting the Diagnosis of ASD
With the complicated emotional reactions many parents experience in response to their
child’s diagnosis of ASD, it is understandable that the process of coming to accept their child’s
diagnosis is often quite difficult for parents. In relation to ASD, acceptance is often described as
involving two components: (a) recognizing the children’s realistic limitations and (b)
maintaining awareness that significant improvement can occur with intervention (Mansell &
Morris, 2004). In this sense, it should be noted that accepting children’s diagnoses of ASD does
not mean believing that the children cannot improve and, therefore, not seeking interventions to
help the children achieve their full potential. In fact, an important component of acceptance is
the realization that vast improvement is possible with high quality intervention.
Despite previous beliefs that parents’ acceptance of their children’s developmental
disabilities improves over time, it has been demonstrated that parents tend to cycle between
phases of despair and acceptance at various stages of their children’s development (Milshtein,
Yirmiya, Oppenheim, Koren-Karie, & Levi, 2010). Furthermore, it has been shown that, on
average, parents of children with ASD report significantly lower levels of acceptance of their
children’s disabilities than do parents of children with other developmental disabilities such as
Down Syndrome (Zembat & Yildiz, 2010). One recent study demonstrated that two-thirds of
mothers and one-half of fathers of children with ASD had not resolved (i.e., did not accept) their
child’s diagnosis (Milshtein, Yirmiya, Oppenheim, Koren-Karie, & Levi, 2010). Although only
a minority of parents of children with ASD achieve full acceptance of their child’s diagnosis,
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parents who have achieved this acceptance often report that coming to terms with their child’s
diagnosis of ASD was an integral and “life changing” step in their journeys to help their children
(Midence & O’Neil, 1999; O’Brien & Daggett, 2006).
Through analyzing in-depth interviews with several parents of children with ASD, Pianta,
Marvin, Britner, and Borowitz (1996) asserted that parents who had achieved acceptance of the
diagnosis of ASD were able to acknowledge the positive and negative consequences of the
diagnosis, did not obsess about the causes of their children’s ASD, and demonstrated realistic
understandings of their children’s abilities and challenges. In contrast, parents who had not
achieved acceptance of the diagnosis demonstrated confusion regarding several aspects of the
diagnosis, held unbalanced views of the consequences of the diagnosis (i.e., all negative or all
positive), lacked energy and motivation, maintained unrealistic beliefs regarding their children’s
abilities and challenges, and often appeared detached from their emotions in relation to the
diagnosis.
Selecting Treatments for a Child with ASD
Parents are also faced with the task of selecting treatments for their children, in addition
to struggling to accept the diagnosis. This is an additional task put on parents immediately upon,
or sometimes prior to, receiving the diagnosis. Parents often view it as overwhelming to sort
through a bewildering number of proposed treatments of unequal effectiveness (e.g., Francis,
2005; NAC, 2009; Valentine, 2010).
Importance of early, evidence-based intervention. It is now widely accepted that early
intervention (i.e., intervention beginning before the age of four) is associated with the most
positive outcomes for children with ASD overall (e.g., Miriam Foundation, 2008; Children’s
Mental Health Ontario, 2003; Rogers, 1996). Although early intervention is important for
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children with many types of disabilities (Ramey & Ramey, 1998), it may be particularly
important for children with ASD as previous studies have demonstrated that young children with
ASD make significantly more gains through intervention than young children with other
developmental disabilities such as Cerebral Palsy (Guralnick, 2005; Rogers, 1996). This finding
may point to a somewhat unique neuroplasticity in young children with ASD, highlighting the
need for intervention during this “critical period” of neurodevelopment (Dawson, 2008; Rogers,
1996).
With the known benefits of early intervention, many parents of children with ASD feel
pressure to select treatments for their children as soon as possible, often without support from
professionals (Hillman, 2006; Lilley, 2011; Valentine, 2010; Wachtell & Carter, 2008).
Unfortunately, this pressure to decide quickly often leaves parents vulnerable to the claims of
many empirically unsupported treatments that the treatments are effective or even offer a cure for
ASD (Francis, 2005). Although there is presently no cure for ASD (Howlin & Moore, 1997;
Roberts, 2004), parents often maintain hope that the ASD will one day disappear (e.g., Danta,
2006). Accordingly, parents often try empirically unsupported treatments with their children
(alone or in combination with other treatments) in the hopes of miracle recovery (Christon,
Mackintosh, & Myers, 2010; Mandell & Novak, 2005). Parents often feel that there is no harm
in trying empirically unsupported treatments with their children. However, this approach risks
wasting the time, energy, and financial resources of children with ASD and their families
(Children’s Mental Health Ontario, 2003).
Additionally, many empirically unsupported treatments for ASD have been associated
with serious side effects. For example, there is a lack of empirical support for medication-based
treatments (used independently) for ASD (Children’s Mental Health Ontario, 2003). Although
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some medication-based treatments such as Haloperidol, Risperidone, and Clomipramine have
been associated with reductions in aggression, self injury, and stereotyped behaviour in
individuals with ASD, they have also been associated with harmful side effects such as sedation,
seizures, and dyskinesias (Children’s Mental Health Ontario, 2003). The gluten/casein-free diet,
touted as a “miracle cure” by celebrity mother Jenny McCarthy (e.g., McCarthy & Kartzinel,
2009), has also been found to be associated with potential medically harmful side effects such as
deficiencies in essential amino acids and suboptimal bone development (Arnold, Hyman,
Mooney, & Kirby, 2003; Heiger, England, Molloy, Yu, Manning-Courtney, & Mills, 2008;
Mulloy, Lang, O’Reilly, Sigafoos, Lancioni, & Rispoli, 2009). Similarly, although facilitated
communication received significant media attention as a key which may unlock the thoughts and
emotions of individuals with ASD, it has been widely discredited due to empirical evidence that
it is most often the thoughts and emotions of treatment facilitators, not individuals with ASD,
being communicated (Perry, Bryson, & Bebko, 1998). As such, this treatment is associated with
many serious risks, including emotional distress to individuals with ASD and their families
(Children’s Mental Health Ontario, 2003).
What is known about parents’ treatment selection. Despite the demonstrated benefits
of early, evidence-based intervention and the risks of empirically unsupported treatments,
empirical support is often not the most influential factor in parents’ treatment selection for their
children with ASD. As one study demonstrated, the four treatments parents most frequently
reported selecting for their children with ASD (i.e., speech therapy, visual schedules, sensory
integration, and applied behavior analysis, respectively) varied significantly in terms of empirical
support (Green et al., 2006). Similarly, Wong and Smith (2006) found that 52% of parents of
children with ASD report having used complementary or alternative (i.e., empirically
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unsupported) treatments with their children, compared to only 28% of parents of children with
typical development.
The mounting evidence that empirical support is not the most influential factor in parents’
treatment selection for their children with ASD has left many clinicians and researchers
wondering which factors are most important in these parents’ treatment selection. Despite the
importance of this question, relatively few empirical studies have been conducted on the topic
and the findings are inconsistent. Callahan, Henson, and Cowan (2008) found that parents’
treatment selection for their children with ASD was significantly influenced by the social
validation of the proposed treatments (i.e., the social acceptability of the goals, procedures, and
outcomes). This finding may be helpful in understanding why some parents continue to select
facilitated communication as a treatment for their children with ASD, despite its demonstrated
ineffectiveness.
There is presently conflicting evidence regarding the influence of children’s
characteristics on parents’ treatment selection. For example, Goin-Kochel et al. (2007) found
that younger children with ASD were more likely to receive behavioural treatments and older
children with ASD were more likely to receive psychopharmacological treatments. Conversely,
however, a more recent study found no associations between children’s ages and the types of
treatments selected by parents (Dardennes, Al Anbar, Prado-Netto, Kaye, Contejean, & Al
Anbar, 2011). In addition, although Goin-Kochel et al. (2007) found that children diagnosed
with Asperger’s Disorder were more likely to receive psychopharmacological treatments than
children diagnosed with Autistic Disorder or Pervasive Developmental Disorder Not Otherwise
Specified, Dardennes et al. (2011) did not find a relation between the severity of children’s ASD
symptomology and the types of treatments selected by their parents.
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These conflicting findings may be better understood by considering methodological
differences between the two studies. For example, Goin-Kochel et al. (2007) used a primarily
American sample of parents (i.e., 77.5% American), while Dardennes et al. (2011) used a sample
of parents from France. The healthcare funding of various ASD treatments varies widely
between these two countries and likely acts as a confounding variable in comparisons between
these studies. In addition, the children of interest in the study by Dardennes et al. (2011) (mean
age = 13.5 years) were much older than the children of interest in the study by Goin-Kochel et al.
(2007) (mean age = 8.3 years). This age difference between the children from each study likely
acts as another confounding variable which must be considered.
Culture may also affect parents’ treatment selection for their children with ASD. One
study found that Latino parents of children with ASD living in Philadelphia were six times more
likely than parents of children with ASD from other cultural groups to select non evidence-based
treatments for their children (Levy, Mandell, Merhar, Ittenback, & Pinto-Martin, 2003).
Similarly, Mandell and Novak (2005) argued that the interaction between the cultural
backgrounds of parents of children with ASD and the resources available in the community may
influence parents’ treatment selection.
Parents’ beliefs about the causes of their children’s ASD have also been shown to affect
their treatment selection. For example, Dardennes et al. (2011) found that parents who blame
early traumatic experiences for their children’s ASD were less likely to select behaviour-based
therapies and the Picture Exchange Communication System (PECS), whereas parents who
attributed cause to an illness during pregnancy were more likely to select psychopharmacological
treatments. Additionally, parents who believed their children’s ASD to be caused by food
allergies were more likely to select detoxification, special diets, and vitamin-based treatments
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and less likely to select psychopharmacological treatments for their children. Finally, parents
who believed that brain abnormalities were a causal factor in their children’s ASD were less
likely to select vitamin-based treatments for their children.
In another study, these researchers also found that parents who held external causal
attributions (i.e., believed in environmental causes) were more likely to select special diets and
vitamin-based treatments (Al Anbar, Dardennes, Prado-Netto, Kaye, & Contejean, 2010). In
Taiwan, Shyu, Tsai, & Tsai, (2010) found that parents who perceived food allergies as having
caused their children’s ASD were more likely to avoid certain food products, while parents who
believed in supernatural causes of their children’s ASD were more likely to try strategies such as
consulting fortune tellers, changing the children’s names, and praying.
Taken together, these findings demonstrate that parents’ treatment selection appears to be
influenced by several interconnected factors, rather than by any one factor alone. A qualitative
study in Taiwan concluded that parents’ treatment selection is influenced by their causal
attributions, perceived treatment effects, children’s preferences, and the fit of the children and
parents with the treatment providers (Shyu, Tsai, & Tsai, 2010). Similarly, Mandell and Novak
(2005) asserted that parents’ perceptions and interpretations of the symptoms of ASD, their
beliefs about the causes and course of the disorder, and their past experiences with healthcare
providers all contribute significantly to parents’ treatment selection for their children with ASD.
Self-regulation model of illness behaviour. A theoretical model which has recently been
applied to the study of parents’ treatment selection for their children with ASD is Leventhal’s
self-regulation model of illness behaviour (Leventhal, Leventhal, & Contrada, 1999; Leventhal,
Meyer, & Nerenz, 1980). This model proposes that individuals form “common sense” cognitive
representations of their illnesses. These cognitive representations consist of individuals’
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judgments regarding five dimensions: (a) identity, (b) cause, (c) consequences, (d) timeline, and
(e) control/cure. The identity dimension includes both the individual’s label for the health threat
(e.g., ASD, diabetes) and the symptoms the individual associates with the threat (e.g., difficulty
communicating, fatigue). The cause dimension represents the individual’s beliefs about the
causes of the health threat (e.g., vaccines, sedentary lifestyle). The consequences dimension
includes both the imagined and real ways in which the individual’s life has been affected by the
health threat (e.g., social isolation, loss of work time). The timeline dimension includes the
individual’s beliefs regarding the length of time over which the health threat developed, the
duration of the health threat, and the length of time necessary for recovery. Finally, the
control/cure dimension of the model represents the extent to which the individual believes the
health threat can be controlled, kept from progressing, and cured.
These five dimensions of illness representations help individuals to formulate an
understanding of the various aspects of their illnesses and enable them to plan their next steps in
response to their health threats. Based on these cognitive representations, individuals select
coping strategies to use in response to various difficulties associated with their illnesses
(Leventhal, Leventhal, & Contrada, 1999; Leventhal, Meyer, & Nerenz, 1980). Additionally,
individuals’ cognitive representations of their illnesses have been demonstrated to predict their
psychological wellbeing (Hagger & Orbell, 2003) and medication adherence (Brewer, Chapman,
Brownlee, & Leventhal, 2002).
Although Leventhal’s model (Leventhal, Leventhal, & Contrada, 1999; Leventhal,
Meyer, & Nerenz, 1980) was originally intended to be applied to individuals’ cognitive
representations of their own illnesses, Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean
(2010) in France have recently applied the model to study parents’ cognitive representations of
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ASD. They aimed to explore the associations between the treatment selection of parents of
children with ASD and the illness perceptions of those parents. In this study, 89 participants
completed the Revised Illness Perception Questionnaire (IPQ-R; Moss-Morris et al., 2002)
modified for ASD, which measured the five dimensions of parents’ cognitive representations of
their children’s ASD (i.e., illness representations). Participants also completed a demographic
questionnaire and indicated which treatments they were currently using or providing for their
children.
Al Anbar et al. (2010) found that parents’ cognitive representations of ASD were
associated with their treatment selection for their children in several specific ways. Parents who
viewed ASD as having more serious consequences for themselves and their children were more
likely to select what the researchers termed “educative treatments” (i.e., behaviour therapy,
social skills therapy, Treatment and Education of Autistic and Communication-related
handicapped Children [TEACH], and the Picture Exchange Communication System [PECS]; p.
821). Parents who held stronger beliefs in a cyclical timeline of ASD were more likely to select
psychopharmacological treatments for their children. Parents who held stronger beliefs in their
ability to control their children’s ASD were also less likely to select metabolic treatments, such
as special diets and vitamin regimens, and psychopharmacological treatments for their children.
Parents who had more negative emotional reactions to the diagnosis of ASD were also less likely
to select behavioural treatments for their children. The researchers found even stronger relations
between parents’ causal beliefs about ASD and their treatment selection for their children.
Specifically, parents who had stronger external causal attributions for their children’s ASD (i.e.,
believed their children’s ASD was caused by environmental factors) were more likely to select
metabolic treatments such as special diets and vitamin regimens for their children.
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Although this study was pioneering in its exploration of the relations between parents’
cognitive representations of ASD and their treatment selection for their children, it had some
limitations. First, participants were given only a “short list of treatments” to indicate “those they
were using or providing for their child” (Al Anbar, Dardennes, Prado-Netto, Kaye, & Contejean,
2010, p. 820). Using this list of treatments in the study likely hindered the identification of
treatments not listed. Additionally, parents were instructed to indicate only which treatments
they were presently using or providing for their children, thus not accounting for previous and
anticipated (i.e., waitlisted) treatments.
Another limitation of this study was that, although the researchers modified the identity
scale of the IPQ-R (Moss-Morris et al., 2002) to include ASD-specific symptoms, they drew
their items from the diagnostic criteria outlined in the Diagnostic and Statistical Manual of
Mental Disorders-III- Revised (APA, 1987), which is now outdated. Finally, the researchers left
the original, general causes of health concerns (e.g., stress, aging, alcohol) items on the Causes
subscale of the IPQ-R (Moss-Morris et al., 2002), and did not add causes often believed to be
associated with ASD (e.g., vaccines, food allergies). Therefore, this measure may not have been
a valid indication of parents’ causal attributions in relation to their children’s ASD.
The Present Study
The present study empirically investigated the relations between parents’ cognitive
representations and their treatment selection for their children with ASD, as an extension of the
exploratory work of Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010). The
limitations of the previous study were addressed by modifying the IPQ-R (Moss-Morris et al.,
2002) to include ASD-specific symptoms as outlined in the DSM-IV-TR (APA, 2000), an
expanded list of treatments which allowed parents to indicate those they were currently using
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with their children as well as past and planned treatments, and a list of ASD-specific causes. In
addition, the present study included a measure of social desirability in order to control for this
potentially confounding variable in all analyses. Since associations between parents’ cognitive
representations of their children’s ASD and their treatment selection have only recently begun to
be studied, the present study also incorporated several exploratory open-ended questions for
qualitative analysis.
As the present study aimed to investigate parents’ treatment selection for their children
with ASD, a participatory action research (PAR) framework was utilized to ensure that the goals,
methods, results, and conclusions of the study were relevant, responsible, and helpful to parents
of children with ASD. PAR is a model of conducting research wherein individuals from the
population of interest (e.g., parents of children with ASD) act as active collaborators in the
research process, rather than passive objects of others’ examination (Whyte, Greenwood, &
Lazes, 1989). Although this philosophy of research is applicable to all researchers working with
living participants, it is believed to be particularly valuable in better understanding and
improving health service delivery to individuals from minority backgrounds (McAllister, Green,
Terry, Herman, & Mulvey, 2003). Within the present study, two mothers of children with ASD
acted as important collaborators (i.e., Parent Advisors) in the research process. These Parent
Advisors were seen as well-qualified for the position as, in addition to each having a child with
ASD, they are both employed in the ASD field, actively involved in the local ASD community,
and are frequently sought out by other parents of children with ASD in the community for
advice.
The original Parent Advisor for the present study helped select the topic of investigation
based on her own experiences and challenges in selecting treatments for her child with ASD, and
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helped to select and refine the measures to ensure that they were accessible and relevant to
parents. She also had an active role in recruiting other parents of children with ASD to
participate in the study. The second Parent Advisor participated in analyzing and interpreting the
obtained results from the study.
As noted by McAllister, Green, Terry, Herman, and Mulvey (2003), including individuals
from the population of interest as coinvestigators in public health-related research is not only a
matter of respect, but also improves the ability of researchers to identify, understand, and
effectively address key public health issues. As such, it is believed that this collaboration with
Parent Advisors in the present study helped to ensure that all aspects of the study addressed
concerns relevant to parents of children with ASD through methods that were likely to yield the
most useful results for individuals with ASD and their families.
An additional contribution of the present study is that it was one of the first studies to
examine parents’ acceptance of their children’s ASD and its associations with their treatment
selection for their children. Although these associations had not been specifically studied in the
past, previous research was interpreted to indicate that specific relations were expected. For
example, it has been shown that parents with higher levels of acceptance of their children’s ASD
have more realistic understandings of the abilities and limitations of their children (Pianta,
Marvin, Britner, & Borowitz, 1996). This finding was interpreted to indicate that parents with
higher levels of acceptance of their children’s ASD may be less likely to select non evidencebased treatments promising a “miracle cure” for their children. Boss (1999) has also asserted
that parents who are still struggling with ambiguous loss and who, therefore, maintain low levels
of acceptance of their children’s ASD often have difficulty making thoughtful decisions on
behalf of their children. This finding was interpreted to indicate that parents with lower levels of
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acceptance of their children’s ASD may be more susceptible to the claims of non evidence-based
treatments and may be more likely to select these treatments for their children.
Several other researchers have conjectured about the relations between parents’
acceptance of their children’s ASD and their treatment selection. For example, in 1997, Siegel
hypothesized that “Parents who are unable to accept their child’s autism… are susceptible to
quick fixes for autism or other treatments not supported by empirical data” (p. 758). Here again
it was hypothesized that parents with lower levels of acceptance of their children’s ASD will be
more likely to select non evidence-based treatments for their children. Similarly, Mandell and
Novak (2005) hypothesized that:
Families that believe autism is a curable condition may follow a treatment regimen
designed to cure the disorder… Families that believe autism is a chronic condition whose
symptoms and related disability may be alleviated but not cured may make different,
perhaps more stable, treatment decisions. (p. 112)
Most recently, a more specific hypothesis regarding the relation between parents’
acceptance of their children’s ASD and their treatment selection has been articulated. When
discussing the results of their study of the effects of acceptance on the wellbeing of fathers of
children with intellectual disabilities, MacDonald, Hastings, and Fitzsimons (2010) mentioned
that:
One would hypothesize that parents better able to stay with difficult emotions [i.e.,
parents with higher levels of acceptance] will be more likely to implement behaviour
management techniques that may initially lead to increased occurrence of aversive
behaviour problems or simply require parents to actively engage with their children.
(p. 35).

PARENTS’ TREATMENT SELECTION

17

This hypothesis suggests that parents with higher levels of acceptance of their children’s ASD
may be more likely to select evidence-based behavioural treatments for their children with ASD.
The purpose of the present study was to identify the relations between parents’ cognitive
representations of their children’s ASD, acceptance of their children’s ASD, and treatment
selection for their children with ASD. It was believed that, if associations were found, this
would have implications for clinicians working with parents during initial diagnosis and
afterwards, particularly since both acceptance and cognitive representations have been
demonstrated to be amenable to change through intervention (Blackledge & Hayes, 2006; Petrie,
Chapman, Ellis, Buick, and Weinman, 2002).
Hypotheses
Hypotheses of the present study were based on both the findings of previous studies and
on untested hypotheses previously offered by researchers studying ASD.
Hypothesis I: Cognitive representations of ASD.
1a: Belief in consequences. It was predicted that parents with cognitive representations
of ASD which include higher beliefs in the severity of ASD and its impact on various aspects of
their children’s functioning (i.e., higher scores on Consequences subscale of the IPQ-RA-E)
would be more likely to select behavioural treatments for their children (e.g., Al Anbar,
Dardennes, Prado-Netto, Kaye, & Contejean, 2010).
1b: Belief in timeline. It was predicted that parents with cognitive representations of
ASD which include higher beliefs in a cyclical course of ASD symptomology (i.e., higher scores
on the Timeline [Cyclical] subscale of the IPQ-RA-E) would be more likely to select medicationbased treatments for their children (e.g., Al Anbar, Dardennes, Prado-Netto, Kaye, & Contejean,
2010).
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1c: Belief in control. It was predicted that parents with cognitive representations of ASD
which include higher beliefs in personal control over ASD (i.e., higher scores on the Personal
Control subscale of the IPQ-RA-E) would be less likely to select medication-based, special diets,
and vitamin-based treatments for their children (e.g., Al Anbar, Dardennes, Prado-Netto, Kaye,
& Contejean, 2010).
1d: External causal beliefs. It was predicted that parents with cognitive representations
of ASD which include higher beliefs in external causes (e.g., pollution, diet, germ or virus, poor
medical care in the past) of their children’s ASD would be more likely to select special diets and
vitamin-based treatments for their children (e.g., Al Anbar, Dardennes, Prado-Netto, Kaye, &
Contejean, 2010).
1e: Emotional representations. It was predicted that parents with more negative
emotional reactions to the diagnosis of ASD (i.e., higher scores on the Emotional
Representations subscale of the IPQ-RA-E) would be less likely to select behavioural treatments
for their children (e.g., Al Anbar, Dardennes, Prado-Netto, Kaye, & Contejean, 2010).
Hypothesis II: Acceptance of children’s ASD.
2a: High acceptance of ASD. It was predicted that parents with higher levels of
acceptance of their children’s ASD (i.e., lower scores on the AAQ-II-A) would be more likely to
select evidence-based treatments for their children (MacDonald, Hastings, & Fitzsimons, 2010;
Mandell & Novak, 2005; Siegel, 1997).
2b: Low acceptance of ASD. It was predicted that parents with lower levels of
acceptance of their children’s ASD (i.e., higher scores on the AAQ-II-A) would be more likely to
select non evidence-based treatments for their children (e.g., MacDonald, Hastings, &
Fitzsimons, 2010; Mandell & Novak, 2005; Siegel, 1997).

PARENTS’ TREATMENT SELECTION
Exploratory. Factors influencing parents’ cognitive representations of ASD and their
acceptance of their children’s ASD were also explored.

19

PARENTS’ TREATMENT SELECTION

20
Method

Participants
Respondents. Participants were 124 parents of children with ASD. In order to
maximize recruitment of participants, no restrictions were placed on the gender of the parent or
the geographic location of the parent in the current study. Participants were recruited by handing
out flyers and speaking with parents at parenting and disability-related events in Ontario through
organizations such as: the Summit Centre for Preschool Children with Autism, the WindsorEssex Chapter of Autism Ontario, St. Mary’s Family Learning Centre, and Autism Services
Incorporated of Windsor and Essex County. In addition, participants were recruited through
advertisements on several online forums and emails sent through parent organizations. For a
complete list of the ASD-related organizations and listservs through which parents were
recruited, please see Appendix A.
The majority of participants (91.1%) were mothers, White (79.8%), and identified
themselves as being married or in common-law relationships (80.6%). 49.2% were in the 35 to
44 year age range. Most participants reported having graduated from college or university
(75.8%) and, although many reported having an annual household income of $75 000 and over
(46%), a substantial portion (21.8%) reported having an annual household income of $25 000 to
$49 999. Most participants were from the United States (45.2%) or Canada (25%); however,
Australia, India, Indonesia, Singapore, and the United Kingdom were also represented in the
sample. For more information regarding the demographic characteristics of participants, please
see Table 1.
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Table 1
Respondent Demographic Information

Variable
Race/Ethnicity (N = 124)
Black
Chinese
Filipino
Latin American
South Asian (East Indian, Pakistani, Sri Lankan, etc.)
Southeast Asian (Cambodian, Indonesian, Laotian, Vietnamese,
etc.)
White
Other
Gender (N = 124)
Male
Female
Age (N = 124)
18 - 34 years
35 - 44 years
45 - 54 years
55 - 64 years
Marital Status (N = 124)
Single
Married/Common Law
Separated
Divorced
Annual Household Income (N = 120)
Under $25,000
$25,000 - $49,999
$50,000 - $74,999
$75,000 and over

Number (%)

2
6
3
2
3

1.6
4.8
2.4
1.6
2.4

2
99
6

1.6
79.8
4.8

10
113

8.1
91.1

20
61
35
7

16.1
49.2
28.2
5.6

8
100
9
6

6.5
80.6
7.3
4.8

11
27
24
57

8.9
21.8
19.4
46.0
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Education (N = 124)
High School or Less
Some College/University
College/University or Post Graduate

7
22
94

5.6
17.7
75.8

Employment Status (N = 122)
Full Time
Part Time
Unemployed
Retired

41
35
42
3

33.1
28.2
33.9
2.4

Current Country of Residence (N = 124)
Australia
Canada
India
Indonesia
Singapore
United Kingdom
United States of America

21
31
3
1
1
2
56

16.9
25.0
2.4
0.8
0.8
1.6
45.2
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Children. The age of the parents’ children was restricted to 21 years and under in the
present study, as the National Standards Report – which was used in the present study to classify
treatments in terms of their levels of empirical support – reviewed the efficacy of proposed
treatments for children with ASD only under the age of 21 (NAC, 2009). The majority of
children (84.7%) were male, White (74.2%), and their mean age was 8.83 years. All parents
reported that their children had received diagnoses on the Autism Spectrum. Their mean age at
diagnosis was 47.87 months. For more information regarding the demographic characteristics of
participants’ children, please see Table 2.
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Table 2
Children Demographic Information
Variable
Race/Ethnicity (N = 123)
Black
Chinese
Filipino
Latin American
South Asian (East Indian, Pakistani, Sri Lankan, etc.)
Southeast Asian (Cambodian, Indonesian, Laotian, Vietnamese,
etc.)
White
Other
Gender (N = 123)
Male
Female

Number (%)

3
4
2
3
3

2.4
3.2
1.6
2.4
2.4

1
92
13

0.8
74.2
10.5

105
18

84.7
14.5
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Materials
Since the present study took place online, the following questionnaires were provided in
electronic format to participants. Therefore, some elements of the formatting were adapted to
accommodate this type of survey distribution. The instructions, items, and rating systems
remained unchanged, however.
Demographic Questionnaire. The questionnaire, designed for this study, consisted of
14 items regarding parent and child demographics (e.g., gender, age, marital status, income,
education, employment status, age at diagnosis, and race/ethnicity) and 1 item regarding
treatments selected in the past, currently being used, or for which parents are currently waitlisted.
For a copy of the demographic questionnaire, please see Appendix B. The list of treatment
options was compiled in accordance with the 37 intervention strategies reviewed by the National
Autism Center (2009). As shown in Table 3, the National Autism Center (2009) classified 11
treatments as empirically “established”, 21 treatments as “emerging”, and 5 treatments as
“unestablished” by reviewing the supporting research evidence and rating each treatment
according to the Scientific Merit Rating Scale (SMRS: NAC, 2009).
The National Autism Center evaluated five dimensions of the supporting evidence in
order to assign a SMRS rating between 0 and 5 to each proposed treatment: (1) research design,
(2) measurement of the dependent variable, (3) measurement of the independent variable or
procedural fidelity, (4) participant ascertainment, and (5) generalization (National Standards
Report, NAC, 2009). SMRS ratings of 3, 4, or 5 indicate that the treatment has been studied
with sufficient scientific rigor to say that the treatment is “established”. SMRS ratings of 2
indicate that the treatment is “emerging”, but that there is not yet enough empirical support
behind the treatment to classify it as established. SMRS ratings of 1 or 0 indicate that the
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Table 3
National Autism Center Classifications of each Reviewed Intervention
Established

Emerging

Unestablished

Antecedent package

Augmentative/alternative
communication device

Academic interventions

Behavioural package

Cognitive behavioural
intervention package

Auditory integration training

Comprehensive behavioural
treatment for young
children

Developmental relationship
based treatment

Facilitated communication

Joint attention intervention

Exercise

Gluten/casein-free diet

Modeling

Exposure package

Sensory integrative package

Naturalistic teaching strategies

Imitation-based interaction

Peer training package

Initiation training

Pivotal response treatment

Language training
(production)

Schedules

Massage/touch therapy

Self management

Multi-component package

Story-based intervention
package

Music therapy
Peer-mediated instructional
arrangement
Picture exchange
communication system
Reductive package
Scripting
Sign instruction
Social communication
intervention
Social skills package
Structured teaching
Technology-based treatment
Theory of mind training

*Note. Classifications based on the Scientific Merit Rating Scale, developed by the National Autism Center.
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treatment is “unestablished”, as it has not yet been studied with sufficient scientific rigor to
substantiate any claims of efficacy in treating ASD.
Revised Illness Perception Questionnaire- Autism (English). For the purposes of the
present study, the Revised Illness Perception Questionnaire-Autism (English) (IPQ-RA-E) was
created by further modifying the Revised Illness Perception Questionnaire first adapted for ASD
by Al Anbar, Dardennes, and Kaye (2010) in France. Permission to use and modify this measure
was obtained from Dardennes (see Appendix C). For a copy of this revised measure, please see
Appendix D.
The Illness Perception Questionnaire (IPQ: Weinman, Petrie, Moss-Morris, & Horne,
1996) was originally developed to quantify individuals’ illness representations in accordance
with Leventhal’s self-regulation model of illness behaviour (Leventhal, Meyer, & Nerenz, 1980).
Unfortunately, low internal consistency within two of the subscales was a limitation of the
measure in its original form (Moss-Morriss, Weinman, Petrie, Horne, Cameron, & Buick, 2002).
Moss-Morris and colleagues (2002) developed the revised Illness Perception Questionnaire
(IPQ-R) to improve the internal consistency of the Control/Cure and Timeline subscales, and to
include newer components of Leventhal’s self-regulation model of illness behaviour (Leventhal,
Leventhal, & Contrada, 1999): cyclical timeline perceptions, illness coherence, and emotional
representations of illness. The IPQ-R is comprised of 73 items representing nine subscales
designed specifically to measure the various aspects of illness representations proposed by
Leventhal’s self-regulation model of illness behaviour (Leventhal, Meyer, & Nerentz, 1980;
Leventhal, Leventhal, & Contrada, 1998): identity, causes, timeline (acute/chronic), timeline
(cyclical), consequences, personal control, treatment control, emotional representations, and
illness coherence.
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The Identity subscale of the IPQ-R is designed to measure the number of symptoms an
individual experiences and the number of symptoms an individual directly attributes to his/her
illness. This subscale is quantified by summing the number of symptoms experienced and the
number of symptoms attributed to the illness (e.g., pain, sleep difficulties). On the remaining
subscales of the IPQ-R, individuals indicate on a 5-point Likert-type scale ranging from
“strongly disagree” to “strongly agree” the extent to which they agree or disagree with a series of
statements. The Cause subscale of the IPQ-R is designed to measure an individual’s beliefs
about the causes of his/her illness (e.g., stress or worry, hereditary). The Timeline
(Acute/Chronic) subscale of the IPQ-R is designed to measure how chronic the individual
perceives the illness to be (e.g., “My illness will last a short time”), while the Timeline (Cyclical)
subscale of the IPQ-R is designed to measure how cyclical or episodic an individual perceives
the course of the illness to be (e.g., “My symptoms come and go in cycles”).
The Consequences subscale of the IPQ-R is designed to measure the negative
consequences an individual perceives are related to his/her illness (e.g., “My illness strongly
affects the way others see me”). The Personal Control subscale of the IPQ-R is designed to
measure the amount of control an individual feels over his/her illness (e.g., “There is a lot which
I can do to control my symptoms”). The Treatment Control subscale of the IPQ-R is designed to
measure the extent to which the individual feels that the illness can be controlled or cured
through treatment (e.g., “My treatment will be effective in curing my illness”). The Emotional
Representations subscale of the IPQ-R is designed to measure an individual’s positive or
negative emotional reactions to the illness (e.g., “I get depressed when I think about my illness”).
Finally, the Illness Coherence subscale of the IPQ-R is designed to measure the extent to which
the individual understands the illness (e.g., “The symptoms of my condition are puzzling to
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me”).
The psychometric properties of the IPQ-R have been studied extensively and are accepted
as an improvement over those of the original IPQ (Figueiras & Alves, 2007; Moss-Morriss et al.,
2002; Wittkowski, Richards, Williams, & Main, 2008). Adequate construct validity of the nine
subscales has been demonstrated through exploratory and confirmatory factor analyses (Hagger
& Orbell, 2003; Moss-Morriss et al., 2002). The nine subscales of the IPQ-R have good internal
reliability, with Cronbach’s alpha values ranging from .79 (Timeline Cyclical) to .89 (Timeline
Acute/Chronic) (Moss-Morriss et al., 2002). The three-week test-retest reliability for each
subscale of the IPQ-R range from .46 to .88, with only the Personal Control subscale having a
correlation below .50 (Moss-Morriss et al., 2002). The test-retest reliability for each subscale of
the IPQ-R has also been examined over six months, demonstrating correlations greater than .5
for all subscales except the Timeline Cyclical subscale.
The subscales of the IPQ-R have adequate discriminant validity with the Positive and
Negative Affect Scale (Watson, Clark, & Tellegen, 1988), with correlations ranging from .01 to
.36 (Moss-Morris et al., 2002). Only the Emotional Representations subscale correlated
somewhat highly (.54) with negative affect. The subscales of the IPQ-R have also been shown to
have adequate known group validity by producing significantly different scores from individuals
with acute pain and individuals with chronic pain (Moss-Morriss et al., 2002). In addition,
illness representations have been shown to account for an additional 15% of variance in Sickness
Impact Profile scores (Bergner, Bobbitt, Carter, & Gilson, 1981) above the 42% of variance
accounted for by illness severity, demonstrating predictive validity (Moss-Morriss et al., 2002).
Additional evidence of the predictive validity of the IPQ-R is that illness representations have
been shown to significantly account for 27% of the variance in physical fatigue and 20% of the
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variance in mental fatigue (Moss-Morriss et al., 2002).
The IPQ-R was first revised for use with parents of children with ASD in 2005 by Al
Anbar, Dardennes, and Kaye. The IPQ-RA (Al Anbar, Dardennes, & Kaye, 2005) consists of 73
French language items measuring the same nine subscales as the IPQ-R: Identity, Causes,
Timeline (Acute/Chronic), Timeline (Cyclical), Consequences, Personal Control, Treatment
Control, Emotional Representations, and Illness Coherence. Al Anbar, Dardennes, and Kaye
(2005) did, however, modify the phrasing of IPQ-R items to assess parents’ representations of
their children’s ASD instead of individuals’ representations of their own illnesses and by
changing the word “illness” in the IPQ-R to the word “disorder” in the IPQ-RA. This was
thought to more accurately reflect the nature of ASD. The symptom checklist in the identity
scale was also modified to include the symptoms of ASD outlined in the Diagnostic and
Statistical Manual of Mental Disorders-III- Revised (APA, 1987).
With the permission of the authors of the IPQ-R and the IPQ-RA, the IPQ-RA-E was
designed by modifying the IPQ-RA in three ways: (1) presenting items in English using the
phrasing from the original IPQ-R (Moss-Morriss et al., 2002), (2) updating the Identity subscale
to include the symptoms of ASD outlined in the Diagnostic and Statistical Manual of Mental
Disorders-IV-TR (APA, 2000), and (3) modifying the Cause subscale to include statements
pertaining to causes more specifically associated with ASD (e.g., vaccine injury). These ASDspecific causes were developed using those mentioned in Furnham and Buck’s (2003) Lay
Beliefs about Autism Questionnaire (as has been done by Dardennes, Al Anbar, Prado-Netto,
Kaye, Contejean, and Al Anbar [2011]) as well as additional causes popularly cited by parents of
children with ASD. This new IPQ-RA-E consists of 78 items.
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Acceptance and Action Questionnaire-II (Autism). The Acceptance and Action
Questionnaire-II (AAQ-II: Bond et al., in press) was used in the present study to assess parents’
acceptance of their children’s ASD. Permission to use and modify this measure was obtained
from Bond (see Appendices E and F, respectively). For a copy of this revised measure, please
see Appendix G.
Originally, the AAQ-II was designed to assess individuals’ general tendencies toward
acceptance (i.e., “the willingness to experience unwanted private events, in order to pursue one’s
values and goals”, [Hayes, Wilson, Gifford, Follette, & Strosahl, 1996]). It was designed to
address the weaknesses of comprehension and reliability inherent in the original AAQ developed
by Hayes et al. (2004). The AAQ-II is comprised of 10 items which are rated on a 7-item Likert
scale ranging from “never true” to “always true” (e.g., “It’s OK if I remember something
unpleasant”).
The psychometric properties of the AAQ-II have been studied recently in 2816
participants across six samples (Hayes et al., 2011) and it was concluded that the AAQ-II
measures the same construct as the original AAQ (r = .97), but has the advantage of improved
psychometric consistency. The AAQ-II has demonstrated good internal reliability, with
Cronbach’s alpha coeffiecients of the six tested samples ranging from .78 to .88 (Hayes et al.,
2011). In addition, the AAQ-II has good three-month test-retest reliability, with a correlation of
.81, and twelve-month test-retest reliability, with a correlation of .79 (Hayes et al., 2011).
In terms of predictive validity, higher scores on the AAQ-II (i.e., more experiential
avoidance) have been found to be associated, as expected, with higher scores on the Beck
Depression Inventory-II (Beck, Steer, & Brown, 1996), higher scores on the Depression Anxiety
Stress Scales (Lovibond & Lovibond, 1995), and greater psychological distress one year later
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(Bond & Hayes, 2002) as measured by the General Health Questionnaire (Goldberg, 1978). The
AAQ-II has also demonstrated adequate convergent validity with the White Bear Suppression
Inventory (Wegner & Zanakos, 1994), with a correlation of .63 (Bond et al., 2002). In addition,
the AAQ-II has demonstrated excellent divergent validity with the Marlowe-Crowne Social
Desirability Scale (Crowne & Marlowe, 1960), with a nonsignificant correlation of -.09 between
these two measures (Bond et al., 2002).
For the purposes of the present study, the AAQ-II was modified to create the Acceptance
and Action Questionnaire-II (Autism) (AAQ-II-A) by rephrasing the 10 items to refer
specifically to individuals’ acceptance in relation to their children’s ASD (e.g., “It’s OK if I
remember something unpleasant about my child with ASD”). This type of modification has also
recently been performed by MacDonald, Hastings, and Fitzsimons (2010) in order to measure
parents’ acceptance of their children’s intellectual disabilities.
Marlowe-Crowne Social Desirability Scale- Short Form. Although the AAQ-II has
been found not to be significantly associated with the Marlowe-Crowne Social Desirability Scale
(Bond et al., 2011), this relation has not yet been studied using the AAQ-II-A or the IPQ-RA-E.
As such, the Marlowe-Crowne Social Desirability Scale- Short Form (MCSDS-SF: Strahan &
Gerbasi, 1972) was included in the present study in order to control for possible confounds
within these measures. Permission to use this measure was not necessary to obtain, since this
measure is in the public domain. For a copy of this measure, please see Appendix H.
The original MCSDS (Crowne & Marlowe, 1960) was developed in order to detect and
quantify individuals’ (intentional or unintentional) attempts to present themselves in a socially
desirable or undesirable light. It was comprised of 33 items consisting of statements which
respondents are asked to judge as “true” or “false” based on their experiences (e.g., “I never
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hesitate to go out of my way to help someone in trouble”).
In terms of psychometric properties, the original MCSDS has demonstrated good internal
reliability, with a calculated reliability coefficient of .88 using the Kuder-Richardson formula
(Crowne & Marlowe, 1960). Additionally, the MCSDS has also been demonstrated to have
excellent one-month test-retest reliability, with a correlation of .89 between tests (Crowne &
Marlowe, 1960). As expected, the MCSDS is also significantly correlated (r = .35) with the
Edwards Social Desirability Scale, demonstrating convergent validity with this measure (Crowne
& Marlowe, 1960).
As the present study involved several measures, a short form of the original MCSDS,
developed by Strahan and Gerbasi (1972), was used in order to minimize potential fatigue effects
and strain on participants. The MCSDS short form (MCSDS-SF: Strahan & Gerbasi, 1972) is
comprised of ten items from the original MCSDS (Crowne & Marlowe, 1960; e.g., “I’m always
willing to admit when I make a mistake”, “I like to gossip at times”). The MCSDS-SF has
demonstrated adequate internal reliability, with calculated reliability coefficients ranging from
.59 to .70 in four different populations (Strahan & Gerbasi, 1972). In addition, the MCSDS-SF
has demonstrated excellent convergent validity with the original MCSDS, with a correlation
above .80 between the measures (Strahan & Gerbasi, 1972).
Open-Ended, Exploratory Survey Questions. Four open-ended, exploratory survey
items were developed specifically for the present study in addition to the previously mentioned
quantitative measures. Please see Appendix I for a copy of these open-ended items. These items
provided parents with the opportunity to respond freely to questions surrounding their goals for
treatment programs, the most important factors in their treatment selection, how their feelings
about ASD have changed since initial diagnosis, and their conceptualizations of ASD.
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In-Depth Interview Questions. In an effort to develop a more in-depth understanding of
how parents think of ASD, acceptance, and treatment selection, a semi-structured follow-up
interview protocol was also developed. This interview consisted of a series of six questions
designed to provide additional insight into parents’ responses to the online questionnaire items.
Parents were asked about what ASD means to them, what has influenced the way they think
about ASD, what it means to accept one’s child’s ASD, what has influenced their acceptance,
what challenges they have experienced in selecting treatments, and what advice they would like
to offer other parents of children with ASD. Please see Appendix J for a copy of these in-depth
interview questions.
Procedure
Participants were asked to follow the link provided in the recruitment advertisements and
flyers to an Internet website that had been set up for the current study. Upon navigating to the
Internet site, participants were presented with a consent form to participate in the online study.
This form contained information regarding the potential benefits and risks of participating in the
present study. Please see Appendix K for a copy of this consent form. For the purposes of the
study, clicking the “Yes” in response to the item “I consent to participate” was taken to indicate
that participants had given their informed consent to participate.
Next, participants were presented with the demographic questionnaire, as Reips (2011)
demonstrated that early presentation of demographic items is associated with lower dropout rates
and fewer missing data in online research. The IPQ-RA (English), the AAQ-II (A), and the
MCSDS were then presented in counterbalanced order (determined by the child’s birth month) to
control for possible fatigue effects. That is, each participant completed each of these three
measures, but their order of presentation varied between participants. At this time, participants
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had the option to respond to several open-ended questions designed to gather exploratory
information regarding factors influencing their cognitive representations of ASD and their
treatment selection for their children. These questionnaires (including both the survey items and
the open-ended items) took participants an average of 51.13 minutes to complete. Although this
completion time was longer than the originally estimated completion time based on pilot testing
with a Parent Advisor (20 minutes), it should be noted that the online administration format of
the survey allowed parents to leave their computers or take short breaks between items. It is
believed that this flexible administration is largely responsible for the longer completion time in
the actual study.
Once all measures were completed, participants were asked to enter their email addresses
if they wanted to participate in a draw for one of ten $20 electronic gift cards as a token of thanks
for participating. This draw took place upon completion of data collection for the present study.
Several smaller incentives were offered in the present study rather than fewer larger incentives in
order to afford participants greater likelihood of being selected and because the monetary value
of incentives has been found to be unrelated to response quality in online research (Goritz,
2004). By presenting participants with an electronic gift card as an incentive, participants’ home
addresses did not need to be obtained, maximizing the participant confidentiality and privacy.
Finally, participants were asked to indicate whether they agreed to be contacted by the primary
researcher for a follow-up interview over the telephone. All participants were then presented
with a printable letter of information describing the background, purpose, and hypotheses of the
current study. This post-study letter of information also contained links to the National
Standards Report (NAC, 2009) and the Evidence-Based Practices for Children and Adolescents
with Autism Spectrum Disorders report (Children’s Mental Health Ontario, 2003), which contain
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thorough reviews of the empirical evidence for several proposed treatments for ASD and
recommendations for parents when selecting treatments for their children. For a copy of this
post-study letter of information, please see Appendix L.
From the participants who agreed to be contacted for the follow-up telephone interview,
ten were selected by convenience to complete these more in-depth interviews. Although only
participants living in the United States and Canada were selected, an effort was made to include
participants from diverse areas of these two countries. These participants were contacted by
telephone, explained what the interview would involve, and assured that confidentiality would be
strictly respected. Interviews were then scheduled with participants who had given their
informed consent to the primary investigator orally. These interviews took place over the
telephone and required approximately twenty minutes to complete. Interviews were digitally
recorded and later transcribed by trained undergraduate research assistants. All data were
collected between June 21, 2012 and August 9, 2012.
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Results

Preliminary Analyses
Before beginning the tests of hypotheses in the present study, the data set was assessed to
identify missing data and outliers. A total of 12 cases were excluded listwise from subsequent
analyses due to a survey host error which resulted in failing to present these participants with the
demographic questionnaire. Only the remaining 134 cases were included for further
examination. Since missing data comprised only 1.44% of this data set, cases containing missing
data were excluded listwise from analyses, as recommended by Schafer (1999). Within the data
set, a total of 5 outliers (i.e., values greater than 2.5 standard deviations from the mean) were
identified and were excluded from subsequent analyses because it appeared that these
participants had meaninglessly endorsed items (e.g., selected “1” for every item in a
questionnaire). An additional 3 participants were excluded from analyses because their children
were born prior to 1991. This left a total of 124 cases in the present data set.
In addition, the extent to which the assumptions of logistic regression had been met in the
data set was determined for the first set of hypotheses. These assumptions include: (a) statistical
independence of outcomes, (b) linearity of the logit, (c) multicollinearity, and (d) adequate
sample size (i.e., 50 participants per predictor variable) (Field, 2009; Wright, 2000). Since each
participant completed the online questionnaire only once, the assumption of independence of
outcomes was said to have been met. Examination of interactions between predictors and their
log transformations did not reveal any significant violations of the assumption of linearity of the
logit. Tolerance values were greater than 0.1 and Variance Inflation Factor (i.e., VIF) values
were less than 10 for each predictor variable, indicating no issues with multicollinearity in the
present data set. Finally, with a total of 124 participants and no more than two predictor

PARENTS’ TREATMENT SELECTION

38

variables per logistic regression analysis, the assumption of adequate sample size was met in the
present data set.
Since the second set of hypotheses in the present study was tested using bivariate
correlations (Pearson’s r), the extent to which the assumptions of this method of data analysis
had been met in the present data set was determined as well. These assumptions include: (a)
interval-level data and (b) a normally-distributed sampling distribution (Field, 2009). The AAQII-A and the section of the Demographic Questionnaire concerning treatments selected by
parents both yield interval-level data, so this assumption was said to have been met in the present
data set. Additionally, the extent to which the assumption of normally-distributed variables was
met in the present data set was determined by examining skewness values, kurtosis values, and
histograms for the variables of interest.
For all variables, the skewness values were between -2 and 2, indicating appropriate
symmetry of the distributions for the variables (Cohen, Cohen, West, & Aiken, 2003). For all
variables, the kurtosis values were between 3 and -3, indicating roughly mesokurtic distributions
(i.e., distributions with appropriately high peaks and sharp tails) (Cohen, Cohen, West, & Aiken,
2003). Finally, visual inspection of the histograms for each variable revealed distributions
approximating normality. Thus, the assumption of normally-distributed variables was said to
have been satisfied in the present data set.
Descriptive statistics. Participants in the present study completed measures of the
treatments they had selected for their children with ASD, their acceptance of their children’s
diagnosis of ASD, and several aspects of their cognitive representation of ASD. The descriptive
statistics for these study variables are outlined below.
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Treatments selected. Parents in the present study reported selecting several treatments
for their children with ASD. The five most commonly selected treatments were antecedent
package, behavioural package, academic interventions, schedules, and gluten/casein-free diet,
respectively. Please see Table 4 for a detailed view of parents’ selections. The treatments
selected by parents were also categorized into levels of empirical support (i.e., established,
emerging, or unestablished) according to the National Standards Report (NAC, 2009). Parents
reported selecting an average of 16 treatments for their children with ASD, the majority of which
were classified as empirically “emerging”. Please see Table 5 for a detailed view of the levels of
empirical support of treatments selected by parents of children with ASD.
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Table 4
Treatments/Interventions Selected by Parents

Intervention
Antecedent package
Behavioural package
Academic interventions
Schedules
Gluten/casein-free diet
Social skills package
Comprehensive
behavioural treatment
for young children
Language training
(production)
Auditory integration
training
Story-based intervention
package
Sensory integrative
package
Exercise
Cognitive behavioural
intervention package
Modeling
Naturalistic teaching
strategies
Augmentative/alternative
communication device
Developmental
relationship-based
treatment
Initiation training
Language training
(production and
understanding)
Self management
Social communication
intervention
Joint attention

#
98
89
87
81
76
76

Total
%
79
71.8
70.2
65.3
61.3
61.3

Past
%
25.8
19.4
16.9
19.4
26.6
17.7

Present
#
%
51
41.1
54
46.9
54
43.5
57
46
31
25
44
35.5

Waitlist
#
%
15
12.1
10
8.1
12
9.7
1
0.8
12
9.7
9
7.3

#
32
24
21
24
33
22

73

58.9

27

21.8

33

26.6

11

8.9

72

58.1

24

19.4

39

31.5

9

7.3

71

57.3

28

22.6

8

6.5

17

13.7

70

56.5

29

23.4

35

28.2

6

4.8

68
67

54.8
54

26
12

21
9.7

28
50

22.6
40.3

13
4

10.5
3.2

61
60

49.2
48.4

11
24

8.9
19.4

37
27

29.8
21.8

13
10

10.5
8.1

60

48.4

16

12.9

36

29

9

7.3

57

46

16

12.9

30

24.2

10

8.1

57
57

46
46

19
17

15.3
13.7

23
32

18.5
25.8

14
8

11.3
6.5

57
57

46
46

11
24

8.9
19.4

35
23

28.2
18.5

11
10

8.9
8.1

54
53

43.5
42.7

15
10

12.1
8.1

22
31

17.7
25

17
12

13.7
9.7
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Scripting
Massage/touch therapy
Picture exchange
communication system
Sign instruction
Music therapy
Peer-mediated
instructional
arrangement
Peer training package
Structured teaching
Exposure package
Imitation-based
interaction
Pivotal response
treatment
Technology-based
treatment
Facilitated
communication
Multi-component
package
Theory of mind training
Other
Reductive package

41

53
52

42.7
41.9

22
27

17.7
21.8

21
19

16.9
15.3

10
6

8.1
4.8

52
44
41
38

41.9
35.5
33.1
30.6

25
28
22
10

20.2
22.6
17.7
8.1

19
11
9
20

15.3
8.9
7.3
16.1

6
5
9
8

4.8
4
7.3
6.5

38
36
32

30.6
29
25.8

12
10
6

9.7
8.1
4.8

17
15
14

13.7
12.1
11.3

9
11
12

7.3
8.9
9.7

32

25.8

13

10.5

14

11.3

5

4

30

24.2

9

7.3

9

7.3

12

9.7

30

24.2

4

3.2

15

12.1

11

8.9

29

23.4

5

4

13

10.5

10

8.1

27
27
21
16

21.8
21.8
19.4
12.9

7
6

5.6
4.8

9
8

7.3
6.5

11
13

8.9
10.5

3

2.4

3

2.4

11

8.9

*Note. Some parents did not indicate when they had used each treatment with their children.
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Table 5
Number of Treatments Selected with each Level of Empirical Support
Empirical Classification

N

M

SD

Min. Max.

Established

121

5.76

3.29

0

11

Emerging

122

7.94

6.11

0

21

Unestablished

124

2.52

1.47

0

5

Total

119

16.26 10.27

0

37

*Note. Empirical classifications are in accordance with the National Standards Report (NAC, 2009).
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Acceptance. Participants completed the AAQ-II-A as a measure of their acceptance of
their children’s diagnosis of ASD. Recall that higher scores on the AAQ-II-A represent lower
levels of acceptance. Table 6 displays the descriptive statistics for the AAQ-II-A.
Cognitive representations of ASD. Participants completed the IPQ-RA-E as a measure
of their cognitive representations of their children’s ASD. For the purposes of the present study,
the Consequences, Cyclical Course, Personal Control, and Emotional Representations subscales
were of interest. Table 6 also displays the descriptive statistics for these subscales of the IPQRA-E.
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Table 6
Descriptive Statistics for Study Variables
Measure/Subscale

N

M

SD

Min. Max.

Consequences Subscale

124

23.96

4.36

13

30

Cyclical Course Subscale

122

11.76

3.19

5

20

Personal Control Subscale

124

23.30

4.98

9

30

Emotional Representations Subscale

122

16.31

7.11

1

30

123

53.93

9.48

29

70

IPQ-RA-E

AAQ-II-A

*Note. Higher scores on the AAQ-II-A represent lower levels of acceptance.
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Tests of Hypotheses
Since the outcome variables for Hypothesis I (a through e) were dichotomous (i.e., “use”
or “non-use” of behavioural, medication-based, or metabolic treatments), binomial logistic
regressions were used in these analyses (Cohen, Cohen, West, & Aiken, 2003). Although
discriminant analysis may also be used in examining relations between several predictors and a
categorical dependent variable, this type of analysis has more restrictive assumptions (e.g.,
normally-distributed predictors; Wright, 2000); thus, logistic regression was used in the present
study. Predictor variables were entered hierarchically in order of their predictive power as
demonstrated by Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010). The
bonferonni adjustment for multiple tests was not used in these analyses in accordance with the
recommendations of Perneger (1998). Since there were only three statistical tests being
performed and hypotheses were informed by previous research, applying the bonferonni
adjustment would likely have over-inflated the type-II error rate (i.e., the chances of failing to
detect a truly significant result) in the present study. Instead, Perneger’s (1998) recommendation
of simply describing each test of significance performed was followed.
Prior to conducting any tests of hypotheses, bivariate correlations between parents’ scores
on the MCSDS-SF and the other variables of interest were examined. Since parents’ scores on
the MCSDS-SF were not significantly correlated with parents’ scores on any of the other
variables of interest, it was unnecessary to include social desirability as a control variable in
subsequent analyses.
Hypothesis I: Cognitive representations of ASD. Table 7 presents a summary of the
results of the logistic regression analyses testing this first set of hypotheses.
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Table 7
Logistic Regression Analyses Predicting Types of Treatments Selected

B

SE

Step Variables Entered
1

2

95% CI for Exp(B)
Wald's χ²
R²
Lower
Upper
Behavioural Treatments
eᵝ

Belief in
Consequences

0.08 0.05

2.16

0.03

1.08

0.97

1.20

Emotional
Representations

0.03 0.04

0.37

0.03

1.03

0.94

1.11

Step Variables Entered
1

2

Medication-Based Treatments

Belief in Cyclical
Timeline

-0.08 0.13

0.40

0.01

0.92

0.70

1.20

Belief in Personal
Control

0.43 0.21

4.12*

0.21

1.54

1.01

2.33

Step Variables Entered

1

2

Metabolic Treatments

Belief in
External Causes

0.33 0.10 11.51**

0.18

1.40

1.15

1.69

Belief in
Personal Control

0.02 0.05

0.19

1.02

0.92

1.13

* p < .05, **p = .001.

0.19
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1a: Belief in consequences. Higher beliefs in the severity of ASD and its impact on
various aspects of one’s child’s functioning did not significantly predict group membership for
selecting behavioural treatments, Block χ² (1, N = 124) = 1.08, ns. Therefore, this hypothesis
was not supported in the present study.
1b: Belief in timeline. Higher beliefs in a cyclical course of ASD symptomatology did
not significantly predict group membership for selecting medication-based treatments, Block χ²
(1, N = 124) = 0.40, ns. Therefore, this hypothesis was not supported in the present study.
1c: Belief in control. Higher beliefs in personal control over one’s child’s ASD
significantly predicted group membership for selecting medication-based treatments, Block χ² (1,
N = 124) = 4.12, p < .05, correctly predicting 93.7% of participants’ group membership. This
model accounted for approximately 21% of the variation in parents’ selection of medicationbased treatments for their children with ASD (Nagelkerke R² = 0.21). Belief in personal control
over one’s child’s ASD was the only significant predictor of selecting medication-based
treatments (B = 0.43, Wald = 4.12, p < .05). Parents with greater beliefs in their personal control
over ASD were more likely to select medication-based treatments for their children (odds ratio =
1.54; 95% CI = 1.01 to 2.33). Therefore, this hypothesis was supported in the present study.
Higher beliefs in personal control over one’s child’s ASD did not significantly predict
group membership for selecting metabolic treatments, Block χ² (1, N = 124) = 1.90, ns.
Therefore, this hypothesis was not supported in the present study.
1d: Belief in external causes. Higher beliefs in external causes (i.e., pollution, diet, germ
or virus, poor medical care in the past, altered immunity, vaccine injury, food allergies, toxic
metals in the bloodstream, videos the child watched) of one’s child’s ASD significantly predicted
group membership for selecting metabolic treatments, Block χ² (1, N = 124) = 11.51, p = .001,
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correctly predicting 71.3% of participants’ group membership. This model accounted for
approximately 18.3% of the variation in parents’ selection of metabolic treatments for their
children with ASD (Nagelkerke R² = 0.183). Belief in external causes of one’s child’s ASD was
a significant predictor of selecting metabolic treatments (B = 0.33, Wald = 11.51, p = .001).
Parents with greater beliefs in external causes of ASD were more likely to select metabolic
treatments for their children (odds ratio = 1.40; 95% CI = 1.15 to 1.69). Therefore, this
hypothesis was supported in the present study.
1e: Negative emotional representations. More negative emotional reactions to one’s
child’s diagnosis of ASD did not significantly predict group membership for selecting
behavioural treatments, Block χ² (1, N = 122) = 0.37, ns. Therefore, this hypothesis was not
supported in the present study.
Hypothesis II: Acceptance of children’s ASD. Table 8 presents a summary of the
results of the bivariate correlation analyses testing this second set of hypotheses.
2a: High acceptance of ASD. Parents’ scores on the AAQ-II-A (which measures
parents’ experiential avoidance of their thoughts and emotions relating to their child’s ASD)
were significantly positively correlated with the number of empirically supported treatments they
selected for their children, r = .179, p < .05. Therefore, data from the study supported an
alternative hypothesis. In other words, parents with higher levels of acceptance of their
children’s ASD selected significantly fewer empirically supported treatments for their children
than did parents with lower levels of acceptance of their children’s ASD. Parents’ acceptance of
their children’s ASD accounted for 3.20% of the variance in the number of empirically supported
treatments they selected for their children, R² = 0.032. According to Cohen (1988), this
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Table 8
Bivariate Correlation Analyses Predicting Empirical Classifications of Treatments Selected
Variables
1. (Lack of) Acceptance

1
-

2. Established Treatments Selected

0.18*

3. Unestablished Treatments Selected

0.21*

*p < .05. **p < .001.

2

3

0.63**

-
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represented a small effect size.
2b: Low acceptance of ASD. Parents’ scores on the AAQ-II-A (which measures parents’
experiential avoidance of their thoughts and emotions relating to their child’s ASD) were
significantly positively correlated with the number of empirically unsupported treatments they
selected for their children, r = .211, p < .05. Therefore, this hypothesis was supported in the
present study. In other words, parents with lower levels of acceptance of their children’s ASD
selected significantly more empirically unsupported treatments for their children than parents
with higher levels of acceptance of their children’s ASD. Parents’ acceptance of their children’s
ASD accounts for 4.45% of the variance in the number of empirically unsupported treatments
they selected for their children, R² = 0.044. According to Cohen (1988), this represented a small
effect size.
Exploratory Quantitative Analyses
Since many of the hypotheses in the present study were not supported by data collected
from the present sample, the data were explored in greater detail in order to more closely
examine possible reasons behind this. The following results should, therefore, be reviewed with
caution, as they were not guided by previous research or subjected to the same level of statistical
scrutiny as the main study findings. As noted by Hand (1998), this type of “data fishing” can be
dangerous because, with enough examination, almost any data set will yield patterns of some
kind. What is not clear without significance testing, though, is whether or not these patterns are
merely the result of random variance.
An unexpected correlation was found between the number of evidence-based treatments
and the number of non evidence-based treatments selected by parents. More specifically, parents
who selected more evidence-based treatments for their children with ASD also reported selecting
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more non evidence-based treatments for their children with ASD, r = .63, p < .001. According to
Cohen (1988), this represented a large effect size.
Additionally, parents (N = 20) who reported selecting the most (i.e., 30 or more)
treatments for their children were compared to parents (N = 11) who reported selecting the
fewest (i.e., 5 or fewer) treatments for their children in an attempt to identify additional variables
which may affect the number of treatments selected by parents. As expected based on other
findings from the present study, parents who reported selecting the most treatments for their
children had AAQ-II-A scores reflecting lower levels of acceptance (M = 51.73) than parents
who reported selecting the fewest treatments for their children (M = 34.15).
Although there were was little difference between the age, education level, or household
income of the parents in either group, children of parents who reported selecting the fewest
treatments were found to be older (M = 13 years) than children of parents who reported selecting
the most treatments (M = 9 years). Children of parents who reported selecting the fewest
treatments were also diagnosed at a later age (M = 51.33 months) than children of parents who
reported selecting the most treatments (M = 36.29 months). Another interesting difference
between parents who reported selecting many treatments and parents who reported selecting few
treatments was their countries of residence. Parents who reported selecting the fewest treatments
lived in Australia (36.4%), the United States (36.4%), and Canada (27.3%), while parents who
reported selecting the most treatments lived in the United States (65%), Canada (20%), Australia
(10%), and India (5%).
It was also of interest to compare parents who selected only empirically supported
treatments for their children (N = 8) to parents who selected only empirically unsupported
treatments for their children (N = 5). Several differences were found between these groups.
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Perhaps most strikingly, parents who selected only empirically supported treatments for their
children had AAQ-II-A scores reflecting higher levels of acceptance (M = 47.12) than parents
who selected only empirically unsupported treatments for their children (M = 60.80).
Additionally, more of the parents who selected only empirically supported treatments for their
children were highly educated (100% reported completing college or postgraduate study) than
parents who selected only empirically unsupported treatments for their children (40% reported
completing some college, 40% reported completing college or postgraduate study, 20% reported
completing high school or less). Parents who selected only empirically supported treatments for
their children identified as White (62.5%), Filipino (25%), and Southeast Asian (12.5%), while
parents who selected only empirically unsupported treatments for their children identified as
White (100%).
In terms of child-related variables, it was found that children of parents who selected only
empirically supported treatments were younger (M = 9 years of age) than children of parents who
selected only empirically unsupported treatments (M = 14 years of age). Similarly, children of
parents who selected only empirically supported treatments were diagnosed at younger ages (M
= 37.25 months of age) than children of parents who selected only empirically unsupported
treatments for their children (M = 64.75 months of age). Finally, children of parents who
selected only empirically supported treatments were diagnosed more recently (M = 37.25 months
ago) than children of parents who selected only empirically unsupported treatments (M = 82.75
months ago).
Parents (N = 11) with the highest levels of acceptance of their children’s ASD (i.e.,
parents with AAQ-II-A scores of 40 or lower) were also compared with parents (N = 11) with the
lowest levels of acceptance of their children’s ASD (i.e., parents with AAQ-II-A scores of 65 or
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higher). It was found that parents with the lowest levels of acceptance had stronger beliefs in
their personal control over their children’s ASD (M = 26) than parents with the highest levels of
acceptance (M = 22.18). Interestingly, parents with the highest levels of acceptance of their
children’s ASD reported having more negative emotional reactions to the diagnosis of ASD (M =
18.36) than did parents with the lowest levels of acceptance (M = 12.91). It also appeared that
more of the parents with the highest levels of acceptance of their children’s ASD were highly
educated (100% reported completing college or postgraduate study) than parents with the lowest
levels of acceptance (72.7% reported completing college or postgraduate study, 27.3% reported
having some college education).
Parents with the lowest levels of acceptance of their children’s ASD reported identifying
as White (81.8%), Black (9.1%), and South Asian (9.1%), while parents with the highest levels
of acceptance reported identifying as White (63.6%), Other, (18.2%), Filipino (9.1%), and South
East Asian (9.1%). Additionally, parents with the lowest levels of acceptance of their children’s
ASD lived in the United States (54.5%), Canada (36.4%), and Australia (9.1%), while parents
with the highest levels of acceptance of their children’s ASD lived in the United States (36.4%),
Canada (27.2%), Australia (18.2%), and India (18.2%). There were no differences between the
two groups on child-related factors.
Next, parents (N = 11) with the most negative emotional reactions to their children’s ASD
diagnoses (i.e., parents with scores of 25 or higher on the IPQ-RA-E emotional representations
subscale) were compared to parents (N = 24) with the least negative emotional reactions to their
children’s diagnoses (i.e., parents with scores of 10 or lower on the IPQ-RA-E emotional
representations subscale) in order to explore possible underlying factors associated with this
construct. It was found that children of the parents with the most negative emotional reactions to
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their children’s diagnoses were diagnosed more recently (M = 43.25 months ago) than were the
children of parents with the least negative emotional reactions to their children’s diagnoses (M =
64 months ago). Interestingly, parents with the most negative emotional reactions to their
children’s diagnoses endorsed more external causes (M = 4.55) for their children’s ASD than did
parents with the least negative emotional reactions to their children’s diagnoses (M = 1.17).
Thematic Analysis of Open-Ended Survey and Interview Questions
Data gathered from the four exploratory items and the in-depth interviews were analyzed
using the method of conducting thematic analysis recommended by Braun and Clarke (2006). In
accordance with this method, data were first read through and initial themes were noted. These
initial themes, developed by the primary investigator, were then read through by the primary
investigator, Parent Advisor, and research advisor for the study and were collated to form larger
themes. One exception to this is that parents’ responses to the four exploratory items were
analyzed by only the primary researcher and the Parent Advisor. Throughout this process, the
specific aspects of each theme were refined and clear definitions and labels were generated for
each theme. Finally, particularly vivid quotations which accurately reflected each theme and the
overall story of the data set were selected for inclusion in the final report. This procedure helped
to ensure that results accurately reflected the experiences of parents of children with ASD.
Themes were reported in order of the number of parents whose comments comprised each theme
(i.e., from most parents to fewest parents).
Ultimate goal for child’s treatment/intervention. Parents (N = 116) responded to the
first open-ended survey item, which asked what their ultimate goal was for their children’s
treatment or intervention programs. The following themes were developed according to the
procedures described above.
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To live a happy and fulfilling life. Parents (N = 27) reported that their ultimate goal for
their children’s treatment was for them to be able to achieve the highest quality of life. For
example, parents’ responses included: “To teach my son skills…so he can have a happy and
productive life”, “For him to live well”, and “I want to improve the quality of his life to the
fullest extent possible”.
To be able to live independently. Parents (N = 25) reported that their ultimate goal for
their children’s treatment was for them to eventually have the ability to live independently. For
example, parents’ responses included: “For him to be independent and successful at what he
chooses to do in life”, “That he be able to function independently”, and “Functional,
independent, tax-paying adult”.
To reach his/her full potential. Parents (N = 24) often reported that their main goal for
their children’s treatment programs is to help their children achieve the most they are capable of.
For example, parents’ responses included: “To help him function better, not to cure” and “For
her to be the best her she can be”.
To fully recover from ASD. Parents (N = 17) reported that their main goal for their
children’s treatment program is for their children to no longer have ASD. For example, parents’
responses included: “Complete indistinguishability from same-age peers”, “Complete recovery”,
and “Back to normal”.
To master specific skills. Parents (N = 16) reported that their ultimate goal for their
children’s treatment program was for their children to gain skills in specific areas. For example,
parents’ responses included: “Verbal appropriate communication, social interactions, and
significant reduction in sensory processing issues”, “For him to achieve developmental, speech,
and physical goals on his peers’ level”, and “I would love her to be able to go to the toilet
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without prompting 100% of the time and say ‘I love you mum’”.
To form relationships with others. Parents (N = 11) reported that their main goal for
their children’s treatment program is for their children to form meaningful relationships with
others. For example, parents’ responses included: “To help him make friends and fit in” and
“Ability to form relationships”.
Most important factor when selecting treatments for a child with ASD. Parents (N =
117) responded to the second open-ended survey item, which asked about the most important
factor to them when they selected treatments for their children with ASD. The following themes
were identified:
How well the treatment works. Parents (N = 24) reported that their main concern when
selecting treatments for their children is how well the treatment works with their children. For
example, parents’ responses included: “That I am able to see results” and “Do they work well
with my child?”.
That the treatment is a good fit for the child. Parents (N = 22) reported that their main
concern when they were selecting treatments for their children was that the treatment addresses
their children’s specific needs and characteristics. For example, parents’ responses included:
“Geared towards his needs”, “How suitable it is for my son”, and “How they will specifically
target a problem my child has on an individual level”.
That the treatment is evidence-based. Parents (N = 21) reported that their main concern
when selecting treatments for their children is that the treatment has empirical support. For
example, parents’ responses included: “The science behind it” and “Research-based with proven
success”.
That the treatment is not harmful. Parents (N = 10) reported that their main concern
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when selecting treatments for their children is that the treatment will not harm their children. For
example, parents’ responses included: “Firstly, that it will not harm my child” and “That they
cause little or no harm to my son’s health or wellbeing”.
Cost and availability of the treatment. Parents (N = 10) reported that practical issues are
their main concern when selecting treatments for their children with ASD. For example, parents’
responses included: “What’s available” and “Money/insurance”.
Advice from professionals and other parents of children with ASD. Parents (N = 9)
reported that advice from professionals working in the field of ASD and other parents of children
with ASD are their main concern when selecting treatments for their children with ASD. For
example, parents’ responses included: “Recommendations by psychologist and pediatrician” and
“Listening to other parents’ experiences”.
Changes in feelings about child’s ASD from diagnosis to present. Parents (N = 116)
responded to the third open-ended survey item, which asked how their feelings about their
children’s diagnoses have changed over time. The following themes were identified:
More accepting of the diagnosis now. Parents (N = 32) reported that their acceptance of
their children’s ASD had increased since their children were diagnosed. For example, parents’
responses included: “I have become more accepting of it but without losing resolve to continue
intensive therapies”, “The immediate grief has passed and I am sometimes hopeful, sometimes
resigned”, and “From grieving to complete acceptance of the diagnosis of my child”.
My feelings have not changed. Parents (N = 19) reported that their feelings about their
children’s diagnosis had not changed at all over time. For example, parents’ responses included:
“Not changed”, “Not really – there is no cure”, and “It’s still very recent, too hard to tell, very
overwhelmed and sad still”.
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More optimistic about child’s future now. Parents (N = 15) also reported feeling more
optimistic about their children’s futures than they had when their children were first diagnosed.
For example, parents’ responses included: “From hopeless to extremely positive”, “More
optimistic now”, and “I am more confident that my child will be successful in what he chooses
for himself in life”.
Better understanding of ASD now. Parents (N = 12) reported that they now had a much
better understanding of ASD than when their children were first diagnosed. For example,
parents’ responses included: “Complete understanding of the condition”, “Better understanding
of the spectrum and influences and effects”, and “I feel more confident now; I know a lot more
about ASD”.
Describing ASD in a single word. Parents (N = 110) responded to the fourth openended survey item, which asked them to describe ASD in one word. Since parents’ responses
varied so widely and did not readily lend themselves to themes, these data are displayed in
Figure 1.
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Parents’ Responses When Asked to Describe ASD in One Word

*Note. Larger fonts indicate more frequently occurring words
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Interview Question 1: Meaning of ASD to parents. Parents (N = 10) who participated
in the in-depth follow-up interview were asked to talk about what ASD meant to them. The
following themes were identified:
Medical explanations. Parents (N = 8) offered somewhat medicalized, scientific
descriptions of ASD. For example, parents’ responses included: “A very complex
disorder…Underneath, there are genuine neurological problems” and “It’s a genetic condition”.
A different way of seeing the world. Parents (N = 4) reported viewing ASD as a different
way of seeing the world. For example, parents’ responses included: “A group of people who
perceive the world differently through their emotions, mentally and physically, and in a sensory
sense” and “Interacting with the world differently”.
Not a tragedy – something that can be lived through. (N = 4) Parents reported viewing a
diagnosis of ASD not as a tragedy but as just another part of life. For example, parents’
responses included: “It’s something that’s not going to be cured. It’s not a death sentence. It’s
not as bad as people make it out to be” and “Nothing necessarily needs to be fixed, but worked
with”.
Pop culture view of ASD. Parents (N = 2) offered descriptions of ASD that reflected
representations of ASD in the media and popular culture. For example, one parent responded,
“My child is exactly like Sheldon from The Big Bang Theory…he says what’s on his mind,
doesn’t understand why it’s not right to tell the truth when the truth will hurt people’s
feelings…”.
Interview Question 2: Factors influencing how parents think about ASD. Parents (N
= 10) who participated in the in-depth follow-up interview were asked to describe the factors that
influence how they think about ASD. The following themes were identified:
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Research, reading, and expert opinion. Parents (N = 7) reported that their views of ASD
were shaped in large part through reading ASD literature and hearing the views of experts in the
field. For example, parents’ responses included: “A lot of books and psychologists…a lot of
research as well” and “Evidence-based research”.
Their own child. Parents (N = 4) reported that their views of ASD were largely shaped
by their experiences with their own child. For example, one parent responded, “My personal
experience with my son”.
Interview Question 3: How parents define acceptance of their children’s ASD.
Parents (N = 10) who participated in the in-depth follow-up interview were asked to describe
what it means to accept one’s child’s diagnosis of ASD. The following themes were identified:
Having a balanced view of the child. Parents (N = 5) described accepting a child’s
diagnosis as maintaining a balanced view of the child and realizing that the child is unique and
not necessarily sick. For example, parents’ responses included: “Realizing that your child is
unique in such a way that is not necessarily going to fit him into the cookie cutter mould that
society has for children and teens” and “You don’t have to fix them. They are who they are”.
Consequences of not accepting a child’s diagnosis. Parents (N = 5) also emphasized the
consequences of not accepting the diagnosis, particularly for the child. For example, one parent
responded, “It’s one of the biggest factors in helping your child…If they can’t accept it then they
are going to do a huge disservice and injustice to the child”.
Not giving up on the child’s potential. Parents (N = 4) conceptualized accepting one’s
child’s diagnosis of ASD as understanding that the child has limitations, but maintaining an
awareness of the child’s potential. For example, one parent responded, “To accept their abilities
and limitations, [although] I’m always pushing their limitations because you don’t want to
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underestimate them”.
End of grieving/mourning process. Parents (N = 2) described accepting one’s child’s
diagnosis of ASD as completing a process of grieving or mourning for the loss of their “hoped
for” child. For example, one parent responded, “There’s this mourning period where you have to
accept that your life is never going to be what you thought it was going to be”.
Interview Question 4: Factors influencing parents’ acceptance of their children’s
ASD. Parents (N = 10) who participated in the in-depth follow-up interview were asked to
outline the factors that they felt influenced their acceptance of their children’s ASD. The
following themes were identified:
Community support or barriers. Parents (N = 6) reported that members of their
communities affected their acceptance of their children’s ASD. Some parents reported that
community members provided support to them, while others reported that community members
acted as barriers to their acceptance of their children’s ASD. For example, parents’ responses
included: “We had a lot of support, which really helped…a lot of professional and family
support” and “Some of our family members didn’t take it well and that’s hard”.
Education. Parents (N = 3) cited learning more about ASD as a major factor which
influenced their acceptance of their children’s ASD. For example, one parent responded, “The
more we understand autism, we get a higher level of acceptance”.
Receiving the diagnosis. Parents (N = 3) reported that receiving the diagnosis of ASD
from a professional increased their acceptance of their children’s ASD. For example, one parent
responded, “The diagnosis – having it confirmed by a professional who you trust”.
Always accepted their child’s ASD. Some parents (N = 2) reported having accepted their
children’s ASD from their first suspicions. For example, one parent responded, “We were the
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ones who noticed something was amiss and then went looking for a diagnosis…I was able to
give up being a ‘normal mother’ right from the get-go”.
Interview Question 5: Parents’ challenges in selecting treatments for children with
ASD. Parents (N = 10) who participated in the in-depth follow-up interview were asked about
their biggest challenges in selecting treatments for their children with ASD. The following
themes were identified:
Knowing which treatments will work. Parents (N = 5) reported experiencing challenges
in knowing which treatments would be effective for their individual children. For example, one
parent responded, “Nothing works for every kid and it’s hard to figure out”.
Forming positive relationships with professionals. Parents (N = 4) reported
experiencing difficulty forming positive working relationships with professionals involved in
their children’s treatment plans. For example, parents’ responses included: “Being able to trust
the service provider” and “Even though we had a diagnosis, the doctors pushed drugs”.
Availability/location. Parents (N = 3) reported that the availability and location of
treatments were challenging factors in their treatment selection. For example, one parent
responded, “Location and offering of treatment”.
Looking into supporting research. Parents (N = 3) reported that having to find and
evaluate the empirical support behind each treatment was challenging during their treatment
selection. For example, one parent responded, “I read research…I wanted to know that scientific
research was done on it”.
Sense of responsibility and guilt. Parents (N = 2) reported that experiencing feelings of
responsibility and guilt in relation to their children made their treatment selection challenging.
For example, one parent responded, “When you take on the responsibility for helping your child
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and they aren’t getting better as fast as you want them to, there’s really no one to point a finger at
but you”.
Cost. Parents (N = 2) reported that the cost associated with certain treatments was a
major challenge for them throughout the process of treatment selection. For example, one parent
responded, “For us and everybody else, one of the biggest challenges is financial”.
Interview Question 6: Advice for other parents selecting treatments for children
with ASD. Parents (N = 10) who participated in the in-depth follow-up interview were asked to
outline their advice for future parents of children with ASD selecting treatments for their
children. The following themes were identified:
Know the services. Parents (N = 5) advised future parents to be knowledgeable about the
services available in their area, currently being used by their children, and currently under study.
For example, parents’ responses included: “Work with professionals that are in your child’s life”
and “Make sure that you understand the services”.
Accept your child’s diagnosis. Parents (N = 3) advised future parents of children with
ASD to quickly accept the diagnosis in order to begin selecting treatments as soon as possible.
For example, parents’ responses included: “Stop trying to make them be something they’re not
and accept them for who they are. I think that will take a lot of pressure off the parents” and
“Don’t be looking for something to cure your child. There’s so many other options out there that
you could be doing to help your child”.
Pay attention to the research. Parents (N = 3) advised future parents to consider the
empirical support behind each treatment when selecting treatments for their children. For
example, one parent responded, “Research. Make sure there is something behind it”.
Trust your instincts. Parents (N = 3) in the present study advised future parents to listen
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to their instincts about which treatments will be best for their children, regardless of empirical or
expert support. For example, one parent responded, “If the things suggested to you don’t feel
right or you really don’t think it’s going to work for your child, don’t do it”.
Find a support system. Parents (N = 2) in the present study advised future parents to
cultivate a support system for themselves involving family, friends, and professionals. For
example, one parent responded, “Find a support group, find some friends that will listen to
you…give you just that shoulder to lean on”.
Be an advocate for your child. Parents (N = 2) advised other parents to take on the role
of an advocate for their children in order to ensure that their children receive the best treatments
possible. For example, one parent responded, “In order to get help for your child, you have to be
that voice they don’t have”.
Additional comments. Parents (N = 10) who participated in the in-depth follow-up
interview were given the opportunity to voice any additional comments they had in regards to
their conceptualizations of ASD, acceptance of ASD, or treatment selection for children with
ASD. One major theme evolved from these comments.
Life goes on – children with ASD can accomplish so much. Parents (N = 3) commented
on the importance of not ruminating on their feelings of loss upon receiving their children’s
diagnoses, but instead to maintain positivity and focus on supporting their children. For
example, parents’ responses included: “Don’t think your world is over because your child has
Autism…their world is just beginning” and “Your child can do a lot more than people might
think and the world might tell you”.

PARENTS’ TREATMENT SELECTION

66
Discussion

The purpose of the present study was to identify the relations between parents’ cognitive
representations of their children’s ASD, acceptance of their children’s ASD, and treatment
selection for their children. Although some of the findings from the French study by Al Anbar,
Dardennes, Prado-Netto, Kaye, and Contejean (2010) were replicated, many were not. This
comparison is explored in greater detail below.
Review of Study Hypotheses
Hypothesis I: Cognitive representations of ASD. Results of the present study
demonstrated that parents’ cognitive representations of their children’s ASD were significantly
related to their treatment selection in certain specific ways.
1a: Belief in consequences. It was predicted that parents with stronger beliefs in the
severity of ASD and its impact on various aspects of their child’s functioning would be more
likely to select behavioural treatments for their children. Results of the present study failed to
support this association. Parents with stronger beliefs in the severity of ASD and its impact on
various aspects of their children’s functioning were not significantly more likely to select
behavioural treatments for their children.
1b: Belief in timeline. It was predicted that parents with cognitive representations of
ASD which include higher beliefs in a cyclical course of ASD symptomology would be more
likely to select medication-based treatments for their children. Results of the present study failed
to support this association. Parents with stronger beliefs in a cyclical course of ASD
symptomology were not significantly more likely to select medication-based treatments for their
children.
1c: Belief in control. It was predicted that parents with cognitive representations of ASD
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which include higher beliefs in personal control over ASD would be less likely to select
medication-based, special diets, and vitamin-based treatments for their children. Contrary to this
prediction, the results of the present study indicated that parents with cognitive representations of
ASD which include higher beliefs in personal control over ASD were more likely to select
medication-based treatments for their children. These stronger beliefs in one’s ability to control
or cure one’s child with ASD may also be reflected qualitatively in the comments of parents who
indicated that that their main goal for their children’s treatment was recovery.
Through conducting post hoc, exploratory analyses, it was found that parents with the
lowest levels of acceptance of their children’s ASD had stronger beliefs in their personal control
over their children’s ASD than did parents with the highest levels of acceptance. It makes
intuitive sense that parents who feel they have a high degree of control over their children’s ASD
experience lower levels of acceptance of their children’s diagnoses (perhaps even believing that
they have the power to “cure” their children). Medication-based treatments likely appeal to these
parents because they operate under the assumption that the child’s ASD is caused by some type
of chemical imbalance within the child which can be counteracted by the medication.
Results of the present study failed to support the hypothesized relation between belief in
personal control over ASD and selection of metabolic (i.e., special diets and vitamin-based)
treatments.
1d: Belief in external causes. It was predicted that parents with stronger beliefs in
external causes of their children’s ASD would be more likely to select metabolic treatments for
their children. Results of the present study supported this hypothesis. This finding is consistent
with previous findings by Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010), who
found that parents with strong environmental causal attributions for their child’s ASD were more
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likely to select nutritional and detoxification treatments for their children. Qualitative data from
the present study indicating that many parents struggle with feelings of responsibility and guilt
over their children’s ASD and experience difficulty finding reliable information may also help to
shed some light on this finding. Parents who believe that an external factor such as receiving a
vaccine cause their children’s ASD are likely more apt to experience feelings of guilt in relation
to their children’s ASD. Similarly, parents who experience greater difficulty accessing accurate
information about the causes of ASD may be more likely to blame external factors such as
vaccines for their children’s ASD.
It is perhaps not surprising that parents who more strongly believed that their children’s
ASD was caused by factors such as vaccine injury, altered immunity, and pollution in the
environment were more likely to select special diet and vitamin-based treatments for their
children. These parents may be attempting to “counteract” the effects of the harmful stimuli
which they believe caused their children to have ASD.
1e: Negative emotional representations. It was predicted that parents with more
negative emotional reactions to the diagnosis of ASD would be less likely to select behavioural
treatments for their children. Results of the present study failed to support this association.
Parents with more negative emotional reactions to their children’s ASD diagnoses were not
significantly less likely to select behavioural treatments for their children.
Hypothesis II: Acceptance of children’s ASD. Since the majority of parents in the
present study reported selecting at least one treatment within each NAC (2009) classification of
empirical support (i.e., established, emerging, unestablished), it was not considered meaningful
to search for associations between parents’ acceptance of their children’s ASD and their
likelihood of selecting a treatment within each category of empirical support. Instead, data were
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examined to determine whether there were relations between parents’ acceptance of their
children’s ASD and the number of treatments parents selected within each classification of
empirical support.
2a: High acceptance of ASD. It was predicted that parents with higher levels of
acceptance of their children’s ASD would report selecting more evidence-based treatments for
their children. Contrary to this prediction, the results of the present study indicated that parents
with higher levels of acceptance of their children’s ASD reported selecting fewer evidence-based
treatments for their children. This result was not consistent with the conjectures of many
researchers studying ASD (e.g., MacDonald, Hastings, & Fitzsimons, 2010; Mandell & Novak,
2005; Siegel, 1997); however, this finding is an important advancement in better understanding
parents’ treatment selection for their children with ASD.
As suggested by the Parent Advisor for the present study after reviewing the qualitative
results, parents with higher levels of acceptance of their children’s ASD may have a more
holistic view of their children’s ASD. That is, they may be more willing to recognize the
positive aspects of their children’s ASD as well as the negative aspects, instead of
conceptualizing their children’s ASD only in terms of symptoms needing to be alleviated.
Therefore, instead of selecting a treatment for each symptom of ASD observed in their children,
parents with higher levels of acceptance may select fewer treatments which they believe will
improve their children’s overall functioning. This notion of parental acceptance of ASD
representing a more holistic view of the child with ASD is consistent with previous research by
Mansell and Morris (2004) and Pianta, Marvin, Britner, and Borowitz (1996), indicating that
parents with higher levels of acceptance of their child’s ASD diagnosis are better able to
acknowledge their children’s strengths as well as challenges.
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2b: Low acceptance of ASD. It was predicted that parents with lower levels of
acceptance of their children’s ASD would report selecting more non evidence-based treatments
for their children. Results of the present study supported this hypothesis. This result may also
be explained by the notion that parents with lower levels of acceptance of their children’s ASD
may have more fragmented, symptom-focused conceptualizations of their children’s ASD. It
may be that their attempts to ameliorate each individual symptom of their children’s ASD leads
them to select more treatments, on average, than parents with higher levels of acceptance who
view their children’s ASD more holistically. This would be consistent with previous research by
Pianta, Marvin, Britner, and Borowitz (1996), which indicated that parents with low levels of
acceptance of their children’s diagnoses of ASD are often confused about several aspects of the
diagnosis and tend to have unbalanced beliefs about the consequences of the diagnosis.
Although the finding that parents with lower levels of acceptance of their children’s ASD
selected both more empirically supported treatments and more empirically unsupported
treatments for their children may seem somewhat paradoxical, the result becomes clearer with
further inspection. What these results actually demonstrate is that parents with lower levels of
acceptance select more treatments for their children in general than parents with higher levels of
acceptance, regardless of empirical support. In other words, it appears that parents with lower
levels of acceptance of their children’s ASD take on a “shotgun approach” to treatment selection,
whereby they try almost every treatment available with their children, regardless of the empirical
support for the treatments. Parents in the present study selected an average of 16 treatments,
with 6 from the empirically “established” classification, 8 from empirically “emerging”, and 2
from empirically “unestablished”. This finding is consistent with results of a study by Call,
Delfs, and Findley (2011) that parents report that they would ideally spread their time and
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financial resources out over several (M = 40.8) treatments for their children with ASD. Findings
from an unpublished manuscript by Drouillard, Gragg, Miceli, and Voelker (2012) that the
majority of parents of children with ASD believe that every treatment is effective in some way
may also shed light on parents’ reasoning behind this “shotgun approach”.
This “shotgun approach” to treatment selection can also be observed in people with
serious illnesses such as cancer. For example, results from a study by Richardson, Sanders,
Palmer, Greisinger, and Singletary (2000) demonstrated that 83.3% of individuals with cancer
reported having used at least one complementary/alternative medicine (CAM) treatment (e.g.,
spiritual practices, vitamins/herbs, special diets). Even more interestingly, 24.7% of the
participants (the largest group in their study) reported using seven or more CAM treatments. In a
similar study, 93.1% of individuals with cancer at the end of life reported using CAM treatments
and use of CAM treatments was associated with longer time spent living with cancer, the
presence of multiple types of cancer, and expectation of cure (Choi et al., 2012). Although this
latter study did not directly examine the number of CAMs used by each participant, the sum of
the number of individuals who reported using each CAM (1093) was much greater than the
sample size of the study (604), indicating that many participants reported selecting multiple
CAMs. When considered in light of these results, it appears that the “shotgun approach” to
treatment selection may be associated with unrealistic hope of recovery or a sense of desperation
in regard to one’s child’s ASD.
Proposed Explanations for Discrepancies between Present and Past Research
Although the present study had much in common with an earlier study conducted by Al
Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010), there were several important
differences which may help to account for the discrepant results. First, participants from the
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present study most commonly reported living in the United States (45.2%) and Canada (25%),
whereas all participants in the Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010)
study lived in France. According to these authors, parents of children with ASD in France often
adopt a more psychological and less medical view of ASD, considering it to be more of a stable
feature than an illness needing to be cured (Al Anbar, Dardennes, Prado-Netto, Kaye, &
Contejean, 2010). In the United States and Canada, a diagnosis of ASD is often seen as a
“personal tragedy”, with parents of children with ASD experiencing significantly more despair
and less hope for their children’s future than do parents of children with typical development
(Hebert & Koulouglioti, 2010).
It is also important to note that the healthcare systems in France and in Canada and the
United States are likely very different. As mentioned by parents in the present study, the cost
associated with a particular treatment is often an important factor for parents when selecting
treatments for their children with ASD. The discrepant healthcare coverage for children with
ASD in different countries, therefore, may have affected the results of the present study and
helps to explain why results are somewhat inconsistent between the present study and Al Anbar,
Dardennes, Prado-Netto, Kaye, and Contejean’s (2010) study.
The children of participants in the Al Anbar, Dardennes, Prado-Netto, Kaye, and
Contejean (2010) study were also older (M = 13.11 years) than children of participants in the
present study (M = 8.83 years). Although Al Anbar, Dardennes, Prado-Netto, Kaye, and
Contejean (2010) found that the ages of children with ASD did not affect the types of treatments
received, an American study by Goin-Kochel et al. (2007) found that younger children with ASD
were more likely to receive behavioural treatments than were older children. This study also
found that older children with ASD were more likely to receive psychopharmacological
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treatments than were younger children (Goin-Kochel et al., 2007). It should be noted that the
children in Goin-Kochel et al.’s (2007) study were much closer in age (M = 8.30 years) to
children in the present study. As also demonstrated in the exploratory quantitative findings of
the present study, parents of younger children tend to try more treatments with their children than
parents of older children, likely due to widespread recognition of the importance of early
intervention. As such, the large age difference between children in the Al Anbar, Dardennes,
Prado-Netto, Kaye, and Contejean (2010) study and the present study likely accounts for some of
the discrepancies in findings between the studies.
An additional factor which may account for much of the discrepancy in results between
the original Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010) study and the
present study is that the original study presented participants with only a “short list of
treatments” (pp. 1139) from which to indicate those they were currently using with their
children. In the present study, participants were presented with a list of 37 treatments in
accordance with those reviewed in depth by the National Autism Center (2009). This expanded
list allowed participants to more accurately report the treatments they had selected for their
children with ASD. Participants in the present study were also asked to specify the treatments
they had used with their child in the past, were currently using, or were on waitlists for. This
allowed for treatments which has been selected by parents for their children but which were not
currently being used by their children to be accounted for in the present study.
All participants in the present study completed the questionnaire online. This differed
significantly from participants in the study by Al Anbar, Dardennes, Prado-Netto, Kaye, and
Contejean (2010) in which over half of the participants completed the questionnaire in penciland-paper format in the presence of a researcher. Although social desirability was not found to
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be significantly associated with any of the variables of interest in the present study, it is possible
that the in-person format of the Al Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010)
study enhanced the influence of social desirability in their sample. Since social desirability was
not controlled for in the statistical analyses performed by Al Anbar, Dardennes, Prado-Netto,
Kaye, and Contejean (2010), it is reasonable to hypothesize that this variable may also help to
explain some of the discrepancy between the results in the original study and in the present
study.
Taken together, although the study by Al Anbar, Dardennes, Prado-Netto, Kaye, and
Contejean (2010) was quite useful as an initial source of hypotheses for the present study, the
differing sample of participants, treatment options, and questionnaire administration options of
this study and the present study created many confounding variables which could not be
accounted for in the statistical analyses conducted in the present study. As such, follow-up
research on the present study should utilize an integration of the exploratory quantitative and
qualitative findings from this study to generate hypotheses which can more accurately be
addressed by the data likely to be collected.
Exploratory Quantitative Findings.
Post hoc analyses of data from the present study revealed that, in addition to lower levels
of acceptance, younger child age and living in the United States were associated with selecting a
greater number of treatments for one’s child with ASD. Parents of younger children with ASD
may not have had a chance to fully come to terms with the implications (both for themselves and
their children) of their children’s diagnoses. It is also possible that this may be explained by a
possible cohort effect for child age. For example, the original paper by Andrew Wakefield and
colleagues, in which it was suggested that the measles, mumps, and rubella (MMR) vaccine was
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implicated in causing ASD, was published in 1998. This paper was not retracted until 12 years
later, in response to a ruling made by the UK General Medical Council’s Fitness to Practice
Panel (Editors of the Lancet, 2010). The treatment selection of many parents of children
diagnosed with ASD after 1998, therefore, was likely affected by this highly publicized study.
As shown in the present study, several parents of children with ASD continue to believe that
their children’s ASD was caused by external factors (e.g., vaccine injury), despite the fact that
this study has now been widely discredited. Additionally, the predominance of the “medical
model” of disability in the United States may lead parents living there to conceptualize ASD as
an illness to be cured instead of a lifelong characteristic which can be improved through
intensive intervention.
Similarly, post hoc analyses revealed that lower levels of acceptance, older child age,
older child age at diagnosis, greater time since diagnosis, lower levels of education, and
identifying as White were associated with selection of empirically unsupported treatments for
one’s child with ASD. Again, it appears as though parents with lower levels of acceptance of
their children’s ASD may not be as concerned with the empirical support behind each treatment
as they are with the purported benefits of each treatment. It generates some hope, however, to
note that parents of younger and more recently diagnosed children appear to be more likely to
select empirically supported treatments than parents of older and less recently diagnosed
children. Perhaps public knowledge of the limitations of the original Wakefield et al. (1998)
study, as well as of the various well-established treatments available for children with ASD, is
increasing over time.
Post hoc analyses also revealed that low levels of acceptance of one’s child’s ASD were
associated with stronger beliefs in personal control over one’s child’s ASD, lower levels of
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education, living in the United States, and identifying as White. It may be that the more
medicalized view of ASD in North America as opposed to other regions yields lower levels of
acceptance of individuals’ disabilities and, instead, favours a more problem-focused approach to
disability. Individuals with lower levels of education may be less likely to challenge these
views, resulting in lower levels of acceptance of ASD among these individuals.
Additionally, post hoc analyses revealed that more negative reactions to one’s child’s
diagnosis of ASD were associated with greater beliefs in external causes of one’s child’s ASD
(e.g., vaccine injury, pollution in the environment). In other words, it appears that parents who
believe that their children were born “typical” but, through some event or stimulus, developed
ASD have lower levels of acceptance of their children’s ASD. This is consistent with research
by Pianta, Marvin, Britner, and Borowitz (1996), which demonstrated that parents who had not
achieved acceptance of their children’s ASD were overly focused on the causes of their
children’s ASD.
Somewhat surprisingly, more negative emotional reactions to one’s child’s diagnosis of
ASD were also found to be associated with higher levels of acceptance. Although this may
initially seem counterintuitive, it makes sense when we recall that the AAQ-II-A actually
measures parents’ willingness to experience uncomfortable thoughts and emotions related to
one’s child’s ASD in order to achieve a certain goal (e.g., selecting a high-quality treatment for
one’s child). It appears that parents with lower levels of acceptance of their children’s ASD may
not allow themselves to fully experience the uncomfortable thoughts and emotions which
naturally arise after receiving the diagnosis of ASD.
An unexpected correlation was also found between the number of evidence-based
treatments and the number of non evidence-based treatments selected by parents. More
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specifically, parents who selected more evidence-based treatments for their children with ASD
also reported selecting more non evidence-based treatments for their children with ASD. This
was the strongest relation found in the present study.

It appears that, although lower levels of

acceptance of one’s child’s ASD are associated with selecting more evidence-based and non
evidence-based treatments for one’s child, a stronger predictor of the number of non evidencebased treatments selected is the number of evidence-based treatments selected. A significant
number of parents seem to be selecting “whatever treatments they can get” for their children,
regardless of the empirical support behind each individual treatment. This inference is also
supported by the finding that, of the five treatments parents most commonly reported selecting,
three (i.e., antecedent package, behavioural package, and schedules) were classified as
empirically “established” and two (i.e., academic interventions and gluten/casein-free diet) were
classified as empirically “unestablished”. As previously discussed, this “shotgun approach” to
treatment selection may be associated with a sense of desperation and unrealistic hope of
recovery for one’s child’s ASD. When considered in light of qualitative findings from the
present study, the “shotgun approach” to treatment selection may also be associated with a more
compartmentalized or symptom-focused conceptualization of ASD. Individuals with this view
may consider each symptom of ASD separately and select a treatment which they believe will
help ameliorate that specific symptom. These parents likely also have lower levels of acceptance
as they may have not yet integrated the various aspects of the diagnosis of ASD into one
inclusive conceptualization.
Exploratory Qualitative Findings
Thematic analysis of qualitative data from the present study was conducted on a
question-by-question basis with the assistance of the parent advisor and the research supervisor
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for the study. For the purposes of the discussion, however, the overarching themes from
responses to the open-ended questions will be examined in greater detail below.
Conceptualizations of ASD. Parents in the present study appeared to hold dichotomous
views in relation to their children’s ASD. An overarching theme representing one of these
viewpoints is that children with ASD do not need to be “fixed” or forced to blend in with
children with typical development. This sentiment is reflected in one mother’s definition of
acceptance of her child’s diagnosis, “Realizing that your child is unique in such a way that is not
necessarily going to fit him into the cookie cutter mould that society has for children and teens”.
Alternatively, another overarching theme which emerged through parents’ responses to
the open-ended questions is that many parents wish for their children with ASD to be “normal”
and no longer show symptoms of ASD. This desire was reflected in the words of one parent who
reported that her biggest goal in her child’s intervention was for her child to achieve “complete
indistinguishability from same-age peers” and another parent who reported that her goal for her
child’s treatment was for her child to achieve “complete recovery”.
These divergent views may provide further evidence for the notion that parents with
higher levels of acceptance of their children’s ASD may view their children more holistically,
while parents with lower levels of acceptance of their children’s ASD may have more
fragmented, symptom-focused views of their child. For example, when asked about their
ultimate goal for their child’s intervention program, several parents offered symptom-focused
responses such as “Verbal, appropriate communication, social interactions, and significant
reduction in sensory processing issues”. When asked the same question, however, several other
parents offered more holistic responses such as “For her to be the best her she can be”. It may be
that the former parent had a higher level of acceptance of his/her child’s ASD than the latter
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parent. Consistent with previous findings that parents’ acceptance of their children’s ASD does
not necessarily increase over time (e.g., Milshtein, Yirmiya, Oppenheim, Koren-Karie, & Levi,
2010), the same parents sometimes offered statements reflecting both sides of this dichotomy in
response to different questions.
Treatment selection. Parents in the present study reported that several factors were
influential in their treatment selection for their children with ASD. The importance of practical
considerations when selecting treatments was a repeated theme throughout parents’ responses to
the open-ended items. Of these practical considerations, the cost and availability of treatments in
their community were the most frequently mentioned. This theme was reflected in the words of
one parent who asserted that “for us and everybody else, one of the biggest challenges [to
selecting treatments] is financial” and another parent who admitted that one of the most
significant challenges she faced when selecting treatments for her child with ASD was the
“location and offering of treatment”.
Besides practical considerations, an additional overarching theme in parents’ responses
was the reported importance placed on empirical support for treatments by parents of children
with ASD. Nearly all parents in the present study reported considering empirical support when
selecting treatments for their children with ASD. For example, one parent described his
treatment selection process, saying “My methods are more research based…I read research…I
wanted to know that scientific research was done on it”, while another parent advised future
parents of children with ASD selecting treatments for their children to “research. Make sure
there is something behind it”.
This finding is interesting when considered in conjunction with other results from the
present study demonstrating that, on average, parents reported selecting 5.76 treatments

PARENTS’ TREATMENT SELECTION

80

classified as empirically “established”, 7.94 treatments classified as empirically “emerging”, and
2.52 treatments classified as empirically “unestablished”. It appears that, although parents report
that empirical support is important to them when selecting treatments for their children with
ASD, their actual treatment selection is not consistent with these reports. One possible
explanation for this discrepancy is that parents may not always fully understand what is meant by
“empirical support” for a given treatment or where this information is available. This
explanation is consistent with previous findings from an unpublished manuscript by Drouillard,
Gragg, Miceli, and Voelker (2012) demonstrating that parents of children with ASD often do not
independently read scientific journal articles to ascertain information about the empirical support
for various proposed treatments. Instead, they frequently report relying on healthcare
professionals, the internet, community ASD organizations, and other parents of children with
ASD for information on the empirical support for various treatments. Unfortunately, these
sources may not always offer valid and reliable information to parents, which may lead many
parents to unknowingly select empirically unsupported treatments for their children.
An additional overarching theme may also help shed light on this discrepancy between
parents’ reported and actual emphasis on empirical support for proposed treatments for ASD.
Parents’ responses to several open-ended questions formed an overarching theme of listening to
their instincts or “gut feelings” when selecting treatments for their children with ASD.
Furthermore, several parents admitted to placing more importance on their parental instincts than
on professional recommendations or empirical support when selecting treatments for their
children. In the words of one mother, “The experts don’t really know any better than you do.
They can just give you options and say ‘Here’s what available and what has worked for other
people’, but only you as a parent know for sure”. In this sense, parents may be considering
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empirical support when selecting treatments for their children with ASD, but simultaneously
placing more importance on their own instincts about which treatments will be most effective
and the “best fit” for their children.
Finally, an overarching theme of the importance of supportive relationships for parents of
children with ASD emerged throughout parents’ responses to several open-ended questions.
Parents in the present study spoke of the importance of social support in a variety of contexts,
such as when coming to terms with their children’s diagnoses and when selecting treatments for
their children. Parents also emphasized the importance of positive relationships not only within
the immediate family, but also within the extended family, with friends, with other parents of
children with ASD, and with professionals working with the child and family. For example,
when asked to offer their advice to future parents of children with ASD, one parent replied “Talk
to other parents… when you speak to other parents you hear stories and what their thoughts are
and all that and that kind of makes it more real so it also gives yourself support”, while another
parent advised future parents to “work with professionals that are in your child’s life…with your
pediatrician, with the school counselor, the teacher ‘cause they see your child…in a light that
you don’t”.
Several parents also spoke of the negative consequences of not having a system of social
support in place. As one mother recalled, “Some of our family members didn’t take [the
diagnosis] well and that’s hard”. Many parents also recalled receiving little support from
professionals working with their children. For example, one mother asserted that “the hardest
challenge is that…the doctors pushed drugs”, while another parent confessed “Sometimes I also
have a lot of frustration with each doctor telling me I’m wrong when I know that I’m not and I
can see my child getting better”.
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Limitations of the Present Study
Recruitment for the present study largely took place online through ASD-related listservs
and organizations. Although many of these organizations were for parents of children with ASD
in general (e.g., Autism Ontario), many of them were also for parents of children with ASD
interested in particular treatments for ASD or proposed causes of ASD (e.g., GFCFkids,
medicaidforhbot, VacInfoCoalition). Many of the groups with the largest online presence
represented non-mainstream opinions in terms of recommended treatments and proposed causes
of ASD. Therefore, individuals with these opinions may have been overrepresented in the
present sample. Additionally, 75% of participants in the study reported having graduated from
college or university. Parents with high levels of education, then, were overrepresented in the
sample and the study findings may be less generalizable to parents who have not graduated from
college or university.
Some of the data collected in the present study were retrospective (e.g., recalling the
length of time parents had used certain treatments with their children). This method may have
compromised the accuracy of the data in some cases, particularly for parents of older children
who may have had to recall treatments used over a decade ago with their child. A related
limitation of the present study is that several parents did not respond to demographic
questionnaire items which asked about when they had used each treatment with their child (in the
past, presently, or future [waitlisted]). Due to this, data about the length of time each treatment
was used with each child could not be examined in the present study.
Parents in the present study were also recruited from diverse geographic locations, mostly
in the U.S., Canada and Australia. This diverse sampling was necessary to accumulate a large
enough sample of parents, but prohibits results of the present study from generalizing to a
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specific group of parents of children with ASD. Also, since parents of children up to the age of
21 participated in the present study, findings do not necessarily apply to parents’ treatment
selection for their children with ASD of certain specific ages.
Strengths of the Present Study
Despite the limitations of the present study, there were also many positive aspects and
improvements on previous research. The present study addressed the limitations of Al Anbar,
Dardennes, Prado-Netto, Kaye, and Contejean’s (2010) study by modifying the IPQ-R (MossMorris et al., 2002) to include ASD-specific symptoms as outlined in the DSM-IV-TR (APA,
2000). The present study also included an expanded list of 37 treatments which allowed parents
to indicate those they were currently using with their children as well as past and planned
treatments. Finally, the present study addressed another limitation of the original study by Al
Anbar, Dardennes, Prado-Netto, Kaye, and Contejean (2010) by revising the Causes subscale of
the IPQ-R to include ASD-specific causes taken from Furnham and Buck’s (2003) Lay Beliefs
about Autism Questionnaire (as has been done by Dardennes, Al Anbar, Prado-Netto, Kaye,
Contejean, and Al Anbar [2011]) as well as additional causes popularly cited by parents of
children with ASD.
The present study was the first to empirically examine the relations between parents’
acceptance of their children’s ASD and their treatment selection for their children. With ASD
researchers long alluding to a possible relation between these constructs, findings taken from the
present study add to the knowledge currently available in the literature. Professionals can use
their knowledge of this established relation between parents’ acceptance of their children’s ASD
and their treatment selection for their children to help foster acceptance from the original
diagnosis of ASD.
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As associations between parents’ cognitive representations of their children’s ASD and
their treatment selection have only recently begun to be studied, an additional strength of the
present study was that it incorporated several exploratory open-ended questions for qualitative
analysis. The findings from these qualitative analyses add a richness to the results of the present
study and help readers to interpret quantitative results in a manner which more accurately reflects
the opinions of parents of children with ASD. The participatory action research framework
utilized in the present study also helped to ensure that the goals, methods, results, and
conclusions of the study were relevant, responsible, and helpful to parents of children with ASD.
Implications and Future Study
Findings from the present study significantly contribute to our knowledge of factors
influencing parents’ treatment selection for their children with ASD and have important
implications for professionals working with parents of children with ASD. Results of the present
study suggest that parents with low levels of acceptance of their children’s ASD often appear to
employ a “shotgun approach” to treatment selection, whereby they try nearly every treatment
available with their children. This means that parents with lower levels of acceptance of their
children’s ASD generally select more treatments for their children and, perhaps more
importantly, select more empirically unsupported treatments for their children with ASD.
Furthermore, this “shotgun approach” also appears to be utilized by individuals with cancer who
hope for complete recovery, particularly those approaching the end of life or who have multiple
types of cancer (e.g., Choi et al., 2012). The parents who employed a “shotgun approach” to
treatment selection in the present study may be similar to these individuals with cancer, selecting
many treatments for their children in the hopes that one of them will be effective in returning
their children to “normal”.
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Workshops focusing on increasing parents’ acceptance of their children’s ASD through
interventions such as Acceptance and Commitment Therapy (e.g., Blackledge & Hayes, 2006)
may therefore be beneficial, especially for parents of newly diagnosed children, in terms of
increasing selection of empirically supported treatments and reducing parents’ likelihood of
selecting empirically unsupported treatments for their children with ASD. Future studies should
evaluate the efficacy of acceptance-focused interventions for the specific purpose of reducing
parents’ selection of unsupported treatments for their children with ASD.
Results of the present study also provide some support for the application of the selfregulation model of illness behaviour (Leventhal, Leventhal, & Contrada, 1999; Leventhal,
Meyer, & Nerenz, 1980) to parents of children with ASD. In the present study, the dimensions
of the model significantly associated with parents’ treatment selection for their children with
ASD were control/cure and cause. Parents’ beliefs about their degree of control over their
children’s ASD was the strongest identified predictor of their treatment selection (i.e., high
beliefs in personal control over one’s child’s ASD predicted selection of medication-based
treatments), while parents’ beliefs about the cause of their children’s ASD were also associated
with their treatment selection (i.e., high beliefs in external causes predicted selection of
metabolic treatments).
Although parents’ acceptance and cognitive representations of their children’s ASD
affected their treatment selection for their children, several other factors are also important to
consider. Of particular importance are practical considerations such as the cost and availability
of each treatment within the local community; support or lack of support from family, friends,
other parents, and professionals; empirical support for each treatment; and parents’ “gut
feelings” about each treatment. Although treatment constraints due to high cost and lack of
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availability in many areas are unfortunate realities for many parents of children with ASD,
factors such as social support and parents’ “gut feelings” about ASD treatments are likely much
more amenable to change. Parents’ instincts are valuable and should certainly not be ignored or
minimized by professionals; however, professionals may use this knowledge to collaborate with
parents when selecting treatments, ensuring that the knowledge they base their decisions on is
accurate. Future research examining the effectiveness of community education seminars and
workshops promoting the importance of these factors in terms of their influence on the quality of
treatments received by children with ASD would be beneficial.
Finally, results of the present study also demonstrated that, although most parents report
that empirical support is an important factor in their treatment selection for their children with
ASD, parents’ actual treatment choices do not consistently reflect this claim. This finding
implies that there is a significant disconnect between research and parents of children with ASD.
It may be that parents of children with ASD do not know where to find reliable information
about the empirical support for various treatments, have difficulty understanding the scientific
literature, or are not aware that the sources of information they most commonly report using (i.e.,
healthcare professionals, the internet, community ASD organizations, and other parents of
children with ASD; Drouillard, Gragg, Miceli, & Voelker, [2012]) are not always reliable.
Future research focusing on better understanding the reasons behind this disconnect between
research and parents, and how to bridge the gap, would likely be beneficial in terms of helping
more parents of children with ASD select empirically supported treatments for their children.
Conclusions
Overall, results from the present study suggest that parents’ treatment selection for their
children with ASD is a complicated process with many influences. Many factors which were
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found to be associated with parents’ treatment selection (e.g., parents’ beliefs about the causes of
their child’s ASD, parents’ beliefs about the empirical support behind proposed treatments) were
often found to be based on inaccurate or unsupported claims. This tendency often leads many
well-intentioned parents to unknowingly select empirically unsupported, or even potentially
harmful, treatments for their children with ASD. Additionally, low levels of acceptance of one’s
child’s diagnosis of ASD was demonstrated to be associated with a “shotgun approach” to
treatment selection, involving selecting significantly more treatments – regardless of empirical
support – than parents with higher levels of acceptance. Parent-focused programs aiming to
increase parents’ knowledge of ASD, its causes, and the evidence behind various proposed
treatments, in addition to programs aiming to increase parents’ acceptance of their children’s
diagnoses of ASD, would likely be beneficial in terms of increasing the likelihood of children
with ASD receiving evidence-based interventions.
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Appendix A: Complete List of ASD-Related Organizations and Listervs used for
Recruiting
ASD-Related Organizations
Summit Centre Preschool for Children with Autism
Autism Ontario, Windsor-Essex Chapter
Autism Ontario
Autism Services Incorporated of Windsor and Essex County
St. Mary's Family Learning Centre
Potential Program, Windsor-Essex Chapter
Potential Program, Hamilton Chapter
Autism Ontario, Chatham-Kent Chapter
Autism Ontario, Durham Chapter
Autism Ontario, Grey Bruce Chapter
Autism Ontario, Halton Chapter
Autism Ontario, Huron-Perth Chapter
Autism Ontario, Kingston Chapter
Autism Ontario, London Chapter
Autism Ontario, Niagara Chapter
Autism Ontario, North Bay Chapter
Autism Ontario, Ottawa Chapter
Autism Ontario, Peel Chapter
Autism Ontario, Peterborough Chapter
Autism Ontario, Sault Ste. Marie Chapter
Autism Ontario, Sudbury Chapter
Autism Ontario, Toronto Chapter
Autism Ontario, Cornwall Chapter
Autism Ontario, Waterloo Chapter
Autism Ontario, Wellington Chapter
OAARSN Adult Autism News Bulletin
Autism Speaks
ASD-Related Listservs
Autism
Autism Society of Greater Tucson
Parents of Autism UK
Sacramento Autistic Spectrum and Special Needs Alliance
AuTeach
64
ABAshop
abasupportgroup
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ABRAutism
actionforautismdiscussion
ActivitySchedules
ADAPTMICHIGAN
aicardisyndromemild
AllergyRelatedVaccineInduce...
appsforautism
ASD_ASER
ASPENBergenCounty
asperger_autism
asperger_autism_12up
asperger_college
AspergersSupport
AspergerSupport
ASSEW_Waukesha
aubiomedgroup
austinasdsupport
aut-home-fam
Aut-N-Indiana
AutDads
autism-adviser
autism-aspergers
autism-comorbidity
autism-CT
autism-cures
autism-diet
AUTISM-FBI
Autism-Florida
Autism-Indiana
autism-indonesia
Autism-Mercury
Autism-Mercury-BioMed-UK
autism-newmexico
autism-oregon
Autism-Software
Autism-Spectrum
autism-stlkids
autism-test-treat
AUTISM-togetherinautismorg
Autism-visual
autism_alabama
Autism_Chatboard
autism_families_delhi
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autism_in_children
Autism_iron
autism_list
autism_marriage
Autism_Mercury
Autism_Recovery
autism_support_group
autism_sweden
autism_talk
Autism_Therapist
Autism_TodayNC
Autism_UK
autism_wa_vctc
autismaba
autismcure
autismfamilycircle
autismfc
autismgrapevine
AutismIndia
AutismInMarin
AutismInNebraska
autisminsanantonio
AutismIowa
autismknowledge
autismmoderatetosevere
autismnvc
autismsocal
AutismUK
Autistic_Spectrum
AutisticDailyLiving
AutisticSelfAdvocacyNetwork
biofeedback
BiomedicalTreatmentforASDinBC
bridgeovertroubledwater4u
Chicago_Talks_Autism_Mind
childdevdelays
childrenwithautism
childrenwithautisum
columbus-autism-support
Crystal_Healing_Foundation
ddshoptalk
DEFEATAUTISM
digidoodlez
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diskusi-autis
doing-the-best-we-can
DTT-NET
EnzymesAndAutism
epilepsycured
FairfaxAutismNetwork
Family_Autism_Center
floortimers
GFCFKids
HDOTherapyforAutism
HENASD
HighFunctioningAutism
Homeschoolers_with_Special_Needs
HomeschoolingAutismToday
HomeschoolingPDDandAutismchild
Hopeforhealingchildren
Houston_Schools_for_ASD
hugsfeelgood
IndianAmericansWithAspergers
jeanandmikec
jewishautisticparents
jewishspecialneeds
kansasautismadvoc
LCCARE
LDS_Autism
LivingWellWithAutism
LosAngelesFamiliesforEffectiveAutismTreatment
medicaidforhbot
Michigan_FEAT
MNAutism-support
mo-feat
MOCHA-Seattle
Nancy Morrison Autism Listserv
NASP-IG-Autism-PDD
NZ_Aspergers
opengaautism
pa_autismsupport
pacdd
panhandleautismsociety
parentsofautisticchildren2
parentsofpddkids
PDD-NOSfamily
pecanbread
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pervasivedevelopmentaldisorder
poac-or
salemco_autism
SCDKids
seattleasnews
secretin_Autism
Seroussi-Info
single-parents-and-autism
SoCal-Autism
southflorida_autism
Special-Education
StemCell_for_Autism2
TEACCH
Texas-Autism-Advocacy
theautismworkshop
transferfactorautism
triautism
UK-oneparent-autism
UTAutismBiomedical
VacInfoCoalition
VitaminK
YaskoProtocol
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Appendix B: Demographic Questionnaire
Please let us know a bit about yourself.
1. Your Gender: a)  Male b)  Female
2. Your Age: a)  18-34 years

b)  35-44

c)  45-54

d)  55-64

e)  65+

3. Your Marital Status:

4. Your Household Income:

a)  Single

a)  Under $25,000

b)  Married and Living with partner

b)  $25,000 - $49,999

c)  Separated

c)  $50,000 - $74,999

d)  Divorced

d)  $75,000 and Over

5. Your Education:

6. Employment Status:

a)  High School or Less

You:

Your Spouse/Partner:

b)  Some College

a)  Full-Time

a)  Full-Time

c)  College or Post-Graduate

b)  Part-Time

b)  Part-Time

c)  Unemployed

c)  Unemployed

d)  Retired

d)  Retired

7. Child’s birthday: month (a) ______ & year (b): _____
8. Is your child (a)  a boy? or (b)  a girl?
9. Child’s birthplace:
City/town (a): _________, province/state (b): ______________, country (c): _______________
10. Your current city/town of residence:
City/town (a):_______________, province/state (b):____________, country (c):__________________
11. Your relationship to your child:
a)  birth parent b)  other caregiver (adoptive/foster parent, grandparent, etc.)
12. Child’s age at diagnosis: My child was ______ months old when diagnosed with autism.
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13. Time since child’s diagnosis: It has been _____ months since my child was diagnosed with autism.
14. Which race or ethnicity do you identify with the most for yourself and for your child?
(Check one in both columns)
Race or Ethnicity
a) Aboriginal
b) Arab
c) Black
d) Chinese
e) Filipino
f) Japanese
g) Korean
h) Latin American
i)

South Asian (East Indian, Pakistani, Sri Lankan, etc.)

j)

Southeast Asian (Cambodian, Indonesian, Laotian,
Vietnamese, etc.)
k) West Asian (Afghan, Iranian, etc.)
l)

White

m) Other (please specify):
___________________________________

a) You

b) Your Child
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15. What treatments for ASD has your child had?
Please check whether each treatment was used in the past (not currently using), is presently being used,
or will be used in the future (currently waitlisted) and indicate the number of months your child
participated in each treatment (if applicable).
Treatment

a) Academic interventions
These interventions are designed to teach
individuals with ASD to recognize and identify
mental states (i.e., a person’s thoughts, beliefs,
intentions, desires and emotions) in oneself or in
others and to be able to take the perspective of
another person in order to predict their actions.

b) Antecedent package
These interventions involve the modification of
situational events that typically precede the
occurrence of a target behavior. These
alterations are made to increase the likelihood of
success or reduce the likelihood of problems
occurring. Treatments falling into this category
reflect research representing the fields of
applied behavior analysis (ABA), behavioral
psychology, and positive behavior supports.

c) Auditory integration training
This intervention involves the presentation of
modulated sounds through headphones in an
attempt to retrain an individual’s auditory
system with the goal of improving distortions in
hearing or sensitivities to sound.

d) Augmentative/alternative
communication device
These interventions involved the use of high or
low technologically sophisticated devices to
facilitate communication. Examples include but
are not restricted to: pictures, photographs,
symbols, communication books, computers, or
other electronic devices.

e) Behavioural package
These interventions are designed to reduce
problem behavior and teach functional
alternative behaviors or skills through the
application of basic principles of behavior
change. Treatments falling into this category

Past

Present

Currently
Waitlisted

Number of
Months Used
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reflect research representing the fields of
applied behavior analysis, behavioral
psychology,and positive behavior supports.

f) Cognitive behavioural intervention
package
These interventions focus on changing everyday
negative or unrealistic thought patterns and
behaviors with the aim of positively influencing
emotions and/or life functioning.

g) Comprehensive behavioural treatment
for young children
This treatment reflects research from
comprehensive treatment programs that involve
a combination of applied behavior analytic
procedures (e.g., discretetrial, incidental
teaching, etc.) which are delivered to young
children (generally under the age of 8). These
treatment programs may also be referred to as
ABA programs or behavioral inclusive program
and early intensive behavioral intervention.

h) Developmental relationship-based
treatment
These treatments involve a combination of
procedures that are based on developmental
theory and emphasize the importance of
building social relationships. These treatment
programs may also be referred to as the Denver
Model, DIR (Developmental, Individual
Differences, Relationship-based)/Floortime,
Relationship Development Intervention, or
Responsive Teaching.

i)

Exercise

These interventions involve an increase in
physical exertion as a means of reducing
problems behaviors or increasing appropriate
behavior.

j)

Exposure package

These interventions require that the individual
with ASD increasingly face anxiety-provoking
situations while preventing the use of
maladaptive strategies used in the past under
these conditions.

k) Facilitated communication
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This intervention involves having a facilitator
support the hand or arm of an individual with
limited communication skills, helping the
individual express words, sentences, or
complete thoughts by using a keyboard of words
or pictures or typing device.

l)

Gluten/casein-free diet

These interventions involve elimination of an
individual’s intake of naturally occurring
proteins gluten and casein.

m) Imitation-based interaction
These interventions rely on adults imitating the
actions of a child.

n) Initiation training
These interventions involve directly teaching
individuals with ASD to initiate interactions
with their peers.

o) Joint attention intervention
These interventions involve building
foundational skills involved in regulating the
behaviors of others. Joint attention often
involves teaching a child to respond to the
nonverbal social bids of others or to initiate joint
attention interactions.

p) Language training (production)
These interventions have as their primary goal
to increase speech production. Examples include
but are not restricted to: echo relevant word
training, oral communication training, oral
verbal communication training, structured
discourse, simultaneous communication, and
individualized language remediation.

q) Language training (production and
understanding)
These interventions have as their primary goals
to increase both speech production and
understanding of communicative acts. Examples
include but are not restricted to: total
communication training, position object
training, position self-training, and language
programming strategies.
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r) Massage/touch therapy
These interventions involve the provision of
deep tissue stimulation.

s) Modeling
These interventions rely on an adult or peer
providing a demonstration of the target behavior
that should result in an imitation of the target
behavior by the individual with ASD. Examples
include live modeling and video modeling.

t)

Multi-component package

These interventions involve a combination of
multiple treatment procedures that are derived
from different fields of interest or different
theoretical orientations. These treatments do not
better fit one of the other treatment “packages”
in this list nor are they associated with specific
treatment programs.

u) Music therapy
These interventions seek to teach individual
skills or goals through music. A targeted skill
(e.g., counting, learning colors, taking turns,
etc.) is first presented through song or rhythmic
cuing and music is eventually faded.

v) Naturalistic teaching strategies
These interventions involve using primarily
child-directed interactions to teach functional
skills in the natural environment. These
interventions often involve providing a
stimulating environment, modeling how to play,
encouraging conversation, providing choices
and direct/natural reinforcers, and rewarding
reasonable attempts.

w) Peer-mediated instructional
arrangement
These interventions involve targeting academic
skills by involving same-aged peers in the
learning process. This approach is also
described as peer tutoring.

x) Peer training package
These interventions involve teaching children
without disabilities strategies for facilitating
play and social interactions with children on the
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autism spectrum. Peers may often include
classmates or siblings. Common names for
intervention strategies include peer networks,
circle of friends, buddy skills package,
Integrated Play Groups™, peer initiation
training, and peer-mediated social interactions.

y) Picture exchange communication
system
This treatment involves the application of a
specific augmentative and alternative
communication system based on behavioral
principles that are designed to teach functional
communication to children with limited verbal
and/or communication skills.

z) Pivotal response treatment
This treatment is also referred to as PRT,
Pivotal Response Teaching, and Pivotal
Response Training. PRT focuses on targeting
“pivotal” behavioural areas — such as
motivation to engage in social communication,
self-initiation, self-management, and
responsiveness to multiple cues, with the
development of these areas having the goal of
very widespread and fluently integrated
collateral improvements.

aa) Reductive package
These interventions rely on strategies designed
to reduce problem behaviors in the absence of
increasing alternative appropriate behaviors.
Examples include but are not restricted to water
mist, behavior chain interruption (without
attempting to increase an appropriate behavior),
protective equipment, and ammonia.

bb) Schedules
These interventions involve the presentation of a
task list that communicates a series of activities
or steps required to complete a specific activity.
Schedules can take several forms including
written words, pictures or photographs, or work
stations.

cc) Scripting
These interventions involve developing a verbal
and/or written script about a specific skill or
situation which serves as a model for the child
with ASD. Scripts are usually practiced
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repeatedly before the skill is used in the actual
situation.

dd) Self management
These interventions involve promoting
independence by teaching individuals with ASD
to regulate their behavior by recording the
occurrence/non-occurrence of the target
behavior, and securing reinforcement for doing
so. Examples include the use of checklists
(using checks, smiley/frowning faces), wrist
counters, visual prompts, and tokens.

ee) Sensory integrative package
These treatments involve establishing an
environment that stimulates or challenges the
individual to effectively use all of their senses as
a means of addressing overstimulation or
understimulation from the environment.

ff) Sign instruction
These interventions involve the direct teaching
of sign language as a means of communicating
with other individuals in the environment.

gg) Social communication intervention
These psychosocial interventions involve
targeting some combination of social
communication impairments such as pragmatic
communication skills, and the inability to
successfully read social situations. These
treatments may also be referred to as social
pragmatic interventions.

hh) Social skills package
These interventions seek to build social
interaction skills in children with ASD by
targeting basic responses (e.g., eye contact,
name response) to complex social skills (e.g.,
how to initiate or maintain a conversation).

ii) Story-based intervention package
These treatments involve a written description
of the situations under which specific behaviors
are expected to occur. Social Stories™ are the
most well-known story-based interventions and
they seek to answer the “who,” “what,” “when,”
“where,” and “why” in order to improve
perspective-taking.
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jj) Structured teaching
Based on neuropsychological characteristics of
individuals with autism, this intervention
involves a combination of procedures that rely
heavily on the physical organization of a setting,
predictable schedules, and individualized use of
teaching methods. These treatment programs
may also be referred to as TEACCH (Treatment
and Education of Autistic and related
Communication-handicapped CHildren).

kk) Technology-based treatment
These interventions require the presentation of
instructional materials using the medium of
computers or related technologies. Examples
include but are not restricted to Alpha Program,
Delta Messages, the Emotion Trainer Computer
Program, pager, robot, or a PDA (Personal
Digital Assistant).

ll) Theory of mind training
These interventions are designed to teach
individuals with ASD to recognize and identify
mental states (i.e., a person’s thoughts, beliefs,
intentions, desires and emotions) in oneself or in
others and to be able to take the perspective of
another person in order to predict their actions.

mm)

Other (please specify):

_______________________________
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Appendix D: IPQ-RA-E
Your views about your child’s Autism:
Listed below are a number of symptoms that you may or may not have observed in your child with
Autism. Please indicate by ticking Yes or No whether you have observed any of these symptoms in
your child, and whether you believe that these symptoms are related to your child’s Autism.
My child has
experienced this
This symptom is
Symptom
symptom since being
related to my child’s
diagnosed with
Autism
Autism
Yes
No
Yes
No
1. Marked impairment in the use of multiple
nonverbal behaviours such as eye-to-eye
gaze, facial expression, body postures, and
gestures to regulate social interaction
2. Failure to develop peer relationships
appropriate to developmental level
3. A lack of spontaneous seeking to share
enjoyment, interests, or achievements with
other people (e.g., by a lack of showing,
bringing, or pointing out objects of interest)
4. Lack of social or emotional reciprocity
5. Delay in, or total lack of, the development
of spoken language (not accompanied by an
attempt to compensate through alternative
modes of communication such as gesture or
mime)
6. Marked impairment in the ability to initiate
or sustain a conversation with others
7. Stereotyped and repetitive use of language
or idiosyncratic language
8. Lack of varied, spontaneous make-believe
play or social imitative play appropriate to
developmental level
9. Encompassing preoccupation with one or
more stereotyped and restricted patterns of
interest that is abnormal either in intensity
or focus
10. Apparently inflexible adherence to specific,
nonfunctional routines or rituals
11. Stereotyped and repetitive motor
mannerisms (e.g., hand or finger flapping or
twisting, or complex whole-body
movements)
12. Persistent preoccupation with parts of
objects

PARENTS’ TREATMENT SELECTION

117

We are interested in your personal views of how you now see your child’s Autism. Please indicate
how much you agree or disagree with the following statements about your child’s Autism by ticking
the appropriate box.

1.
2.
3.
4.
5.
6.
7.
8.
9.

10.
11.

12.

13.

14.
15.
16.
17.

18.
19.

Views about your child’s
Autism
My
1 child’s Autism will last a
short time.
My
2 child’s Autism is likely to be
permanent rather than temporary.
My
3 child’s Autism will last for a
long time.
My
4 child’s Autism will pass
quickly.
I expect
5
my child to have Autism
for the rest of his/her life.
Autism is a serious disorder.
My child’s Autism has major
consequences on my life.
My
8 child’s Autism does not have
much effect on my life.
My
9 child’s Autism strongly
affects the way others see
him/her.
My
1 child’s Autism has serious
financial consequences.
My
1 child’s Autism causes
difficulties for those who are
close to him/her.
There
1 is a lot which I can do to
control my child’s Autism
symptoms.
What
1 I do can determine whether
my child’s Autism gets better or
worse.
The
1 course of my child’s Autism
depends on me.
Nothing
1
I do will affect my
child’s Autism.
I have
1 the power to influence my
child’s Autism.
My
1 actions will have no effect on
the outcome of my child’s
Autism.
My
1 child’s Autism will improve
in time.
There
1 is little that can be done to
improve my child’s Autism.
2

Strongly
disagree

Disagree

Neither
agree nor
disagree

Agree

Strongly
agree
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20.

21.

22.
23.
24.
25.
26.
27.
28.

29.
30.

31.
32.

33.
34.
35.
36.
37.
38.

My child’s treatment(s) will be
effective in curing his/her Autism.
The
2 negative effects of my child’s
Autism can be prevented
(avoided) by his/her treatment(s).
My
2 child’s treatment(s) can
control his/her Autism.
There
2 is nothing which can help
my child’s Autism.
The
2 symptoms of my child’s
Autism are puzzling to me.
My
2 child’s Autism is a mystery to
me.
I don’t
2
understand my child’s
Autism.
My
2 child’s Autism doesn’t make
sense to me.
I have
2 a clear picture or
understanding of my child’s
Autism.
The
2 symptoms of my child’s
Autism change a great deal from
day to day.
My child’s Autism symptoms
come and go in cycles.
My
3 child’s Autism is very
unpredictable.
My
3 child goes through cycles in
which the symptoms of his/her
Autism get better and worse.
I get
3 depressed when I think about
my child’s Autism.
When
3 I think about my child’s
Autism I get upset.
My
3 child’s Autism makes me feel
angry.
My
3 child’s Autism does not worry
me.
My
3 child having Autism makes
me feel anxious.
My
3 child having Autism makes
me feel afraid.
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Causes of my child’s Autism
We are interested in what you consider may have been the cause of your child’s Autism. As people
are very different, there is no correct answer for this question. We are most interested in your own
views about the factors that caused your child’s Autism rather than what others including doctors
or family may have suggested to you. Below is a list of possible causes for your child’s Autism.
Please indicate how much you agree or disagree that they were causes for your child by ticking the
appropriate box.

Possible Causes

1. Stress or worry
2. Hereditary- it runs in my
family
3. A germ or virus
4. Diet or eating habits
5. Chance or bad luck
6. Poor medical care in his/her
past
7. Pollution in the environment
8. His/her own behaviour
9. His/her mental attitude (e.g.,
thinking about his/her life
negatively)
10. Family problems or worries
11. Overwork
12. His/her emotional state (i.e.,
feeling down, lonely,
anxious, empty)
13. Ageing
14. Alcohol
15. Smoking
16. Accident or injury
17. His/her personality

Strongly
Disagree

Disagree

Neither
Agree
nor
Disagree

Agree

Strongly
Agree
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18. Altered immunity
19. Vaccine(s)
20. Food allergies
21. Toxic metals in bloodstream
22. Videos he/she watched
23. My own behaviours/actions
24. His/her actions in a past life
25. Reproductive technologies
used in his/her conception
26. Illness during pregnancy
27. Brain abnormalities
28. Chemical imbalance

In the spaces below, please list in rank-order the three most important factors that you now
believe caused your child’s Autism. You may use any of the items from the box above, or you may
have additional ideas of your own.
The three most important causes in my opinion:
1. _______________________________________
2. _______________________________________

3. _______________________________________
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Appendix G: AAQ-II-A
Below you will find a list of statements. Please rate how true each statement is for you by circling a
number next to it. Use the scale below to make your choice.
1
Never
true

2
Very
seldom true

3
Seldom
true

4
Sometimes
true

5
Frequently
true

6
Almost
always true

7
Always
true

1. It’s okay if I remember something unpleasant about my child
1 2 3 4 5 6 7
having Autism.
2. My painful experiences and memories of my child having Autism
1 2 3 4 5 6 7
make it difficult for me to live a life that I would value.
3. I’m afraid of my feelings toward my child having Autism.
1 2 3 4 5 6 7
4. I worry about not being able to control my worries and feelings
1 2 3 4 5 6 7
toward my child having Autism.
5. My painful memories about my child having Autism prevent me
1 2 3 4 5 6 7
from living a fulfilling life.
6. I am in control of how Autism affects my life.
1 2 3 4 5 6 7
7. My emotions about my child having Autism cause problems in my 1 2 3 4 5 6 7
life.
8. It seems like most parents of children with Autism are handling
1 2 3 4 5 6 7
their problems better than I am.
9. Worries about my child having Autism get in the way of my
1 2 3 4 5 6 7
success.
10. My thoughts and feelings related to my child having Autism do not 1 2 3 4 5 6 7
get in the way of how I want to live my life.
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Appendix H: MCSDS-SF
Listed below are a number of statements concerning personal attitudes and traits. Read each item
and decide whether the statement is true or false as it pertains to you personally.
Item
1. I’m always willing to admit it when I make a mistake.
2. I always try to practice what I preach.
3. I sometimes try to get even rather than forgive and forget.
4. I never resent being asked to return a favour.
5. I like to gossip at times.
6. At times I have really insisted on having things my way.
7. I have never deliberately said something that hurt
someone’s feelings.
8. There have been occasions when I felt like smashing things.
9. There have been occasions when I took advantage of
someone.
10. I have never been irked when people expressed ideas very
different from my own.

True

False
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Appendix I: Open-Ended, Exploratory Survey Items
1. What is your ultimate goal for your child’s treatment/intervention?
2. What is the most important thing to you when selecting treatments/interventions for your
child?
3. How have your feelings about your child’s ASD changed from when he/she was first
diagnosed to now?
4. If you could describe ASD in one word, it would be _______________.
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Appendix J: In-Depth Interview Questions

1. What does ASD/Autism mean to you?

2. What factors do you think influence how you think about Autism?

3. What do you think it means to accept that your child has Autism?

4. What factors do you think influence your acceptance of your child’s Autism?

5. What were your major challenges in selecting treatments for your child with Autism?

6. What advice do you have for other parents selecting treatments for their children with
Autism?
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Appendix K: Consent Form

LETTER OF INFORMATION AND CONSENT TO PARTICIPATE IN RESEARCH
Title of study: It’s all in how you see it: Predicting parents’ treatment selection for their children
with Autism Spectrum Disorder
You are asked to participate in a study by Brianne E. Drouillard, B.A. (Hons.), from the
Psychology Department at the University of Windsor as part of her Master’s degree in Child
Clinical Psychology.
Dr. Marcia Gragg, Ph.D., C. Psych., is supervising the study. If you have any questions or
concerns, please feel free to contact Dr. Gragg at (519) 253-300, Ext. 2227.
PURPOSE OF THE STUDY
The study will examine the extent to which various factors predict parents’ treatment selection
for their children with ASD. This information may help professionals in guiding parents toward
selection of evidence-based treatments for their children with ASD.
PROCEDURES
If you volunteer to participate in the study, you will be asked to provide responses to various
questions online. This will take approximately 20 minutes.
You will also be given the opportunity to provide written responses to four open-ended questions
concerning your goals for your child’s treatment/intervention program, your reactions to your
child’s diagnosis of ASD, and how you think about your child’s ASD.
POTENTIAL RISKS
You might feel mild discomfort, anxiety, or sadness while answering the questions as you recall
receiving your child’s diagnosis, think about your child having ASD, and think about how you
selected treatments for your child. You can access professional support by dialing 416-4862242 (in Canada) or 1-800-273-8255 (in the United States) should you require help with
psychological reactions as a result of participating in this study.
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POTENTIAL BENEFITS TO PARTICIPANTS AND/OR SOCIETY
You may benefit directly by feeling more confident in your treatment selection decisions for
your child with ASD and/or by confronting your feelings associated with your child’s diagnosis.
Alternatively, you may not directly benefit from taking part in this study. However, you will be
providing information which may help future parents to select evidence-based interventions for
their children with ASD.
PAYMENT FOR PARTICIPATION
To thank you for participating in this study we offer you the opportunity to enter a draw for one
of ten $20 electronic gift cards to Amazon.com/ca. If you are the winner of a gift card, it will be
emailed by September 30, 2012 to the email address you provide.
CONFIDENTIALITY
Any information gathered in connection with this study and that can identify you will remain
confidential and will not be disclosed without your permission. The researchers will keep the
data from this study locked in a secure location for seven years after the study is completed. All
data and forms will be shredded or deleted after seven years.
We may wish to use your information from this study in future research studies. Your
information will still be confidential and identified only by an identification number.
PARTICIPATION AND WITHDRAWAL
You can choose whether to be in this study or not. If you volunteer to be in this study, you may
withdraw at any time before you submit your questionnaire online without consequences of any
kind. You may also refuse to answer any questions you do not want to answer and remain in the
study. Once you have submitted your questionnaire, you will no longer be able to withdraw your
information as there will be no way to identify and locate your specific questionnaire.
If you do not wish to take part in the study once you have started, simply exit the questionnaire.
You will be sent directly to the Draw page and you can enter the Draw even if you choose to
withdraw from the study. If you would like to participate, complete the questionnaire and submit
it. You will be sent directly to the Draw page after you have clicked submit.
FEEDBACK OF THE RESULTS OF THE STUDY TO THE PARTICIPANTS
A brief summary of the results of the research will be available by October 31, 2012 and will be
posted online at http://www.uwindsor/ca/autism
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RIGHTS OF RESEARCH PARTICIPANTS
You may withdraw your consent at any time and discontinue participation without penalty. If
you have questions regarding your rights as a research participant, please contact: Research
Ethics Coordinator, University of Windsor, Windsor, Ontario, N9B 3P4, (519-253-3000, Ext.
3948), Email: ethics@uwindsor.ca
SIGNATURE OF RESEARCH PARTICIPANT
I understand the information provided for the study It’s all in how you see it: Predicting
parents’ treatment selection for their children with Autism Spectrum Disorder as described
in this document. My questions have been answered to my satisfaction, and I agree to participate
in this study.
SIGNATURE OF INVESTIGATOR
There are the terms under which I will conduct research.

_(signature of investigator will be electronically inserted)_

[Click to consent]

________________
Date

[Click to decline]

Click here to print a copy of the Letter of Information and Consent to Participate for your
records.
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Appendix L: Post-Study Letter of Information

Title of study: It’s all in how you see it: Predicting parents’ treatment selection for their children
with Autism Spectrum Disorders
You participated in a study by Brianne E. Drouillard, B.A. (Hons.) from the Psychology Department
at the University of Windsor. This study is part of her Master’s degree in Child Clinical Psychology.
Dr. Marcia Gragg, Ph.D., C. Psych., is supervising the study. If you have any questions or concerns,
please feel free to contact Dr. Gragg at mgragg@uwindsor.ca or Brianne at drouillb@uwindsor.ca.
PURPOSE OF THE STUDY AND BACKGROUND INFORMATION

With the widespread use of unsupported treatments for Autism Spectrum Disorders (ASD), it
is important to identify factors associated with selection of these treatments that may be
possible to change.

Two of the most challenging tasks for parents of recently diagnosed children are developing
an understanding of ASD and accepting the diagnosis of ASD.

The purpose of the present study is to identify the relations between nine aspects of parents’
understandings of ASD, their acceptance of their children’s ASD, and their treatment
selection for their children.

EXPECTED FINDINGS OF THE STUDY
a) Parents with stronger beliefs in the severity of ASD and its impact on various aspects of their
child’s functioning will be more likely to select behavioural treatments for their children;
b) Parents with stronger beliefs in a cyclical course of ASD will be more likely to select drugbased treatments for their children;
c) Parents with stronger beliefs in their personal control over their child’s ASD will be less likely
to select drug-based, diet-based, and vitamin-based treatments for their children;
d) Parents with stronger beliefs in external causes of their child’s ASD (e.g., vaccines, pollution)
will be more likely to select diet-based and vitamin-based treatments for their children;
e) Parents with more negative emotional reactions to their child’s diagnosis of ASD will be less
likely to select behavioural treatments for their children;
f) Parents with higher levels of acceptance of their child’s ASD will be more likely to select
supported treatments for their children; and
g) Parents with lower levels of acceptance of their child’s ASD will be more likely to select
unsupported treatments for their children.
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FEEDBACK OF THE RESULTS OF THE STUDY TO THE PARTICIPANTS
A brief summary of the results of the research will be available by February 1, 2013 and will be
posted online at www.uwindsor.ca/autism (click on ‘Student Research’ and ‘Brianne Drouillard’).
PSYCHOLOGICAL SUPPORT
You can access professional support by contacting your family physician or by dialing 1-800-4481833 for the Canadian National Crisis Hotline or 1-800-273-8255 for the US National Crisis Hotline,
should you require help with psychological reactions as a result of participating in this study.
MORE INFORMATION ON SELECTING TREATMENTS FOR CHILDREN WITH ASD
For more information on the empirical support for various treatments for children with ASD and tips
on how to select the best treatments for your child, please visit:
http://www.kidsmentalhealth.ca/documents/EBP_autism.pdf
and
http://www.nationalautismcenter.org/pdf/NAC%20Standards%20Report.pdf

PARENTS’ TREATMENT SELECTION
Vita Auctoris
NAME:

Brianne Elizabeth Drouillard

PLACE OF BIRTH:

Windsor, Ontario

YEAR OF BIRTH:

1987

EDUCATION:

St. Anne Secondary School
2001 – 2005
University of Western Ontario
2005 – 2010 B.A. (Honours)
University of Windsor
2010 – 2012 M.A.

132

